Lax security on October 20, 2010 at entrance to McDonald's restaurant at HP building at Harrison, Malate,Manila.The guard at said entrance, didn't inspect my luggage or subject said luggage to scanning with metal detector. Said luggage was large enough to contain grenades and firearms. After leaving said restaurant, I proceeded to other parts of said building. The guard at the exit of said restaurant leading to the major part of said building didn't inspect said luggage or subject said luggage to scanning with metal detector. I went to Mercury Drug store within said building
and bought products. Proof of purchase is Mercury drug corporation cash sales invoice dated 10-20-10 and numbered
20808851.
While I was in said building, I bought food from Tokyo Ventures, Inc. Proof of purchase is Tokyo Ventures, Inc.invoice No. 10190 dated Oct. 20, 2010.No visible required express lane for senior citizens and no visible prominently displayed
sign, etc. regarding privileges of senior citizens. I believe said entity violated
the implementing rules and regulations of the Expanded Senior Citizens Act of 2003. In addition, the employee who served me didn't have visible health certificate displayed at the proper position on the clothing he was wearing.
While I was in said building on said date, I also entered National book store, The guard at entrance to said store didn't inspect said luggage or subject said luggage to scanning with metal detector. No visible required express lane
for senior citizens and no visible prominently displayed sign, etc. regarding privileges of senior citizens. I believe said entity violated the implementing rules and regulations of the Expanded Senior Citizens Act of 2003.
Civil Service Commission ignored by Manila Mayor Lim?
I have a a copy of a letter identified as from a Maria Luisa Salonga-Agamata Director IV Public Assistance and Information Office Civil Service Commission addressed to said Lim and dated September 28, 2010 regarding Manila City's Health Department. Up to October 20, 2010, said Lim has not provided me with a reply to said letter.
Manila govt. Sta. Ana hospital subject of complaint received by DILG
For the benefit of the poor, I wrote to said hospital and requested the names of the doctors working at said hospital, etc. Said request was made through a letter
sent via registered mail to said hospital. Said letter was designated as registered letter No. 2973 and was mailed at the postal station at Robinsons Ermita.
Based on the registry return receipt for said letter, said letter was received by said hospital on 5-13-2010. Up to October 20, 2010, said hospital has not provided me with acknowledgment that it received said letter and has not informed me what it did regarding the contents of said letter.
advisory re buying goods/services in Mandaluyong
I have evidence vs. Mandaluyong Mayor Benjamin Abalos, Jr. I believe he violated R.A. 6713. I have a registry return receipt for my registered letter No. 3456
addressed to said Mayor. Based on the information on said receipt, said letter was received by said Mayor's agent on or about Feb. 18, 2010. Despite R.A. 6713,
which said Mayor is supposed to obey, up to October 20, 2010, said Mayor has not provided me with acknowledgment that he received said letter. I have evidence the
Department of the Interior and Local Government has received my complaint vs. said Mayor. Said Mayor has not helped me regarding my complaints vs. Power Nut food store, Complink, SM HyperMart, etc.
Manila Health Department refused to accept my letter? Said letter is addressed to the Manila Health Department. Said letter was mailed on April 25, 2010. Based on the marking on the envelope of said letter, said department refused to accept said letter Based on my records, said envelope contained the following message:
"Manila Health Department, City Hall, Manila
Please, soonest, provide me with a clear, complete copy of the latest
inspection report re Bruno's Barbers store at Robinsons Place Malate, Manila"
Advisory vs. Manila Mayor Lim.I have seen many stores in Manila which did not have express lanes for senior citizens in the customer areas of said stores and
did not have signs, etc.in the customer areas of said stores regarding the privileges of senior citizens.
Rule IX Article 11 of Republic Act No. 9257 contained the following statement: "It shall be the responsibility of the municipality/city through the Mayor to
require all establishments covered by the Act to prominently display posters, stickers, and other notices that will generate public awareness of the rights and
privileges of senior citizens and to ensure that the provisions of the Act are implemented to its fullest."
Evidence vs. Concepcion Carrier Air Conditioning
On June 1, 2010, I sent the following message by registered mail, to the president of Concepcion Carrier Air Conditioning. The letter was designated
as registered letter No. 5292: "The following was published in an ad regarding Carrier brand air conditioners: "to i-cool . . . saves you up to 65% in
electricity>" Provide soonest, to me, proof, if any, that said feature saves up to 65% in electricity." Based on the registry return receipt for said
letter, said letter was received on June 7, 2010 by said president's agent. Up to October 20, 2010, said president has not provided me with a reply to
said letter.
Advisory re Kolinphil.An ad regarding Kolinphil air conitioners was published on page 6 of the Sunday October 17, 2010 issue of the Philippine Star newspaper.
Said ad contained the following claims: "Energy Savings up to 50%"; "it's the latest technology"; "stronger air discharge"; "Quiet operation"; "more precise settings";
"reliable after-sales service nationwide". For their own benefit, customers are advised to, before buying said airconditioners, require said corporation to provide
proofs, if any, to back up said claims.
Philippine Department of Health Toy Safety Tips Advisory
http://www.doh.gov.ph/advisory/toy_safety.html
Things to remember in choosing toys for children:
Characteristics of a good toy:
1. Suitable to the child’s physical capabilities, mental and social development;
2. Appealing and interesting to the child; and
3. Well constructed, durable and safe for the child’s age.
Do’s and Dont’s in Toy Safety:
1. Check labels on the packaging and observe precautions appearing in the labels to ensure the safety of the child;
2. Ensure that the child will play with a toy suited for his age under adult supervision;
3. Dispose plastic packaging accordingly. Keep it out of reach of children;
4. For children under age three (3), do not buy the following toys:
• balls with a diameter of 1.75 inches or less so as to prevent choking;
• that easily breaks into small parts or pieces (glass or brittle plastics);
• containing small detachable parts or pieces which could become lodged in the throat;
• with sharp points and edges;
• with electrical parts, unless supervised by an adult;
• with parts that could pinch or entrap fingers, toes or hair;
• with parts put together by straight pins, sharp wires or nails that are exposed and easily detached.
For inquiries, please call the Bureau of Health Devices and Technology (BHDT)-Department of Health at 743-8301 local 3408 or at 711-6824.
SUBJECT: ADDITIONAL REMINDER
The Administrative Order No. 2007-0032 entitled “Regulations on the Issuance of a License to Operate to Companies that Manufacture, Import or Distribute Toys for the
Philippine Market” was already issued and can be downloaded at our website at http://www.doh.gov.ph.
Related Links
* P.D. 881: Empowering the Secretary of Health to Regulate the Labelling, Sale & Distribution of Hazardous Substance
* Republic Act 7394 - The Consumer Act of the Philippines
* Toy Safety Tips Advisory .pdf file
Got Mice? Seal, Trap, and Clean Up to Control Rodents
http://www.cdc.gov/Features/Rodents/
Rodents may enter your home for food or shelter. Seal up holes or gaps in your home, trap any existing rodents, and
clean up any sources of food or water and items that might provide shelter for them.
Mice and rats are pesky critters that can enter your home through small holes or gaps. Mice can squeeze through a hole the size of a nickel, and rats can squeeze through a hole the size of a half quarter!
Worldwide, rats and mice are the cause of over 35 diseases! In the United States, rodents can spread diseases like hantavirus pulmonary syndrome, rat-bite fever, leptospirosis, and lymphocytic choriomeningitis virus, a virus that poses a particular risk for pregnant women. If rodents invade your home this fall or winter, here are a few steps to protect yourself and your family.
Rats! What To Do about Rodents!
If you find signs of rodents or their droppings in your home, take precautions to clean up the area safely.
* Seal up holes or gaps in your home to prevent rodents from returning.
Mice can squeeze through a hole the size of a nickel, and rats can squeeze through a hole the size of a half dollar! Prevent rodents from entering the home by checking inside and outside the house for gaps or holes.
Where to look for gaps or holes inside your home
* Inside, under, and behind kitchen cabinets, refrigerators and stoves.
* Inside closets near the floor corners.
* Around the fireplace.
* Around doors.
* Around the pipes under sinks and washing machines.
* Around the pipes going to hot water heaters and furnaces.
* Around floor vents and dryer vents.
* Inside the attic.
* In the basement or crawl space.
* In the basement and laundry room floor drains.
* Between the floor and wall juncture.
Where to look for gaps or holes outside your home
* In the roof among the rafters, gables, and eaves.
* Around windows.
* Around doors.
* Around the foundation
* Attic vents and crawl space vents.
* Under doors.
* Around holes for electrical, plumbing, cable, and gas lines.
Fill small holes with steel wool. Put caulk around the steel wool to keep it in place. Use lath screen or lath metal, cement, hardware cloth, or metal sheeting to fix large holes. These materials can be found at your local hardware store. Fix gaps in trailer skirtings and use flashing around the base of the house. If you do not remember to seal up entry holes in your home, rodents will continue to get inside. Outbuildings and garages should also be sealed to prevent the entrance of rodents.
* Page last reviewed: July 29, 2010
* Page last updated: July 29, 2010
* Trap rodents in and around your home using an appropriate snap trap.
Trap rodents around the home to help reduce the rodent population
Baiting a snap trap with peanut butter.
Choose an appropriate snap trap. Traps for catching mice are different from those for catching rats. Carefully read the instructions before setting the trap.
When setting the trap, place a small amount of peanut butter (approximately the size of a pea) on the bait pan of the snap trap. Position the bait end of the trap next to the wall so it forms a "T" with the wall. Rodents prefer to run next to walls or other objects for safety and do not being out in the open.
In attics, basements, and crawlspaces and other areas that do not have regular human traffic, set traps in any area where there is evidence of frequent rodent activity. Some rodents, particularly rats, are very cautious and several days may pass before they approach the traps. Other rodents, such as house mice and deer mice, are less cautious and may be trapped more quickly.
Position a snap trap so it forms a "T" with the wall.
We do not recommend using glue traps or live traps. These traps can scare mice that are caught live and cause them to urinate. Since their urine may contain germs, this may increase your risk of being exposed to diseases.
Also place traps in outbuildings and in areas that might likely serve as rodent shelters. Natural rodent predators, such as non-poisonous snakes, owls, and hawks, may also help control and reduce the number of rodents outside the home.
If you trap inside your home, but do not seal up rodent entry holes, new rodents will enter the dwelling. For information on how to seal up holes inside and outside the home, please see the Seal Up! page.
* Clean up any sources of food or water, and items that might provide shelter for rodents.
Clean up rodent food sources and nesting sites
various food containers with properly sealed lids
Keep food in thick plastic or metal containers with tight lids.
Prevent contact with rodents by cleaning up your home, workplace, or campsite.
Eliminate possible rodent food sources
* Keep food in thick plastic or metal containers with tight lids.
* Clean up spilled food right away and wash dishes and cooking utensils soon after use.
* Keep outside cooking areas and grills clean.
* Always put pet food away after use and do not leave pet-food or water bowls out overnight.
* Keep bird feeders away from the house and utilize squirrel guards to limit access to the feeder by squirrels and other rodents.
* Use a thick plastic or metal garbage can with a tight lid.
* Keep compost bins as far away from the house as possible (100 feet or more is best).
* Keep grains and animal feed in thick plastic or metal containers with tight lids. In the evening, uneaten animal feed should be returned to containers with lids.
If storing trash and food waste inside the home, do so in rodent-proof containers, and frequently clean the containers with soap and water. Dispose of trash and garbage on a frequent and regular basis, and pick up or eliminate clutter.
Eliminate possible nesting sites outside the home. Elevate hay, woodpiles, and garbage cans at least 1 foot off the ground. Move woodpiles far away from the house (100 feet or more is best). Get rid of old trucks, cars, and old tires that mice and rats could use as homes. Keep grass cut short and shrubbery within 100 feet of the home well trimmed.
* Page last reviewed: July 29, 2010
* Page last updated: July 29, 2010
* Content source: Centers for Disease Control and Prevention
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Division of High-Consequence Pathogens and Pathology (DHCPP
web sites with free useful information:
http://www.airsafe.com/
airsafe web site
http://www.onlineschools.org/resources/brain/
onlinesschools org web site
http://www.bbc.co.uk/religion/religions/
BBC Religion
http://www.labtestsonline.org/
labtestsonline org web site
National Center for Emerging and Zoonotic Infectious Diseases
http://www.cdc.gov/ncezid/
U.S. FDA warning letters
Posted on October 14, 2010
Letter Issue Date Company Name Issuing Office Subject Close Out Date
October 12, 2010 Evenbetternow, LLC Los Angeles District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 Longevity Plus, LLC Los Angeles District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 Artery Health Institute LLC New York District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 Hormonal Health, LLC Los Angeles District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 Dr. Rhonda Henry San Francisco District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 World Health Products, Inc. Denver District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 Maxam Nutraceutics Seattle District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 Cardio Renew Inc Minneapolis District Office Unapproved New Drugs/Misbranded Not Issued *
Posted on October 12, 2010
Letter Issue Date Company Name Issuing Office Subject Close Out Date
October 08, 2010 Rx-promotion Center for Drug Evaluation and Research Internet Marketing of Unapproved and Misbranded Drugs Not Issued *
October 06, 2010 Fresh Express Incorporated San Francisco District Office False & Misleading Claims/Misbranded Not Issued *
October 04, 2010 Gold Coast Trading Co. New York District Office Seafood HACCP Not Issued *
September 30, 2010 O'Barr, Thomas Jr., M.D. Center for Drug Evaluation and Research Clinical Investigator Not Issued *
September 29, 2010 Newberry Farms, LLC Detroit District Office Animal Sale for Slaughter as Food/Adulterated Not Issued *
September 29, 2010 Snow, Lamar L. M.D. Center for Drug Evaluation and Research Clinical Investigator Not Issued *
September 23, 2010 Mundt & Associates, Inc. Center for Devices and Radiological Health Electronic Product Radiation Control Not Issued *
September 21, 2010 Nature's Health Company, LLC Center for Food Safety and Applied Nutrition Unapproved New Drug/Lacks New Drug Application/Misbranded Not Issued *
September 13, 2010 Nissin Food Co Inc. USA Center for Food Safety and Applied Nutrition Labeling/Misbranded Not Issued *
August 18, 2010 MN Airlines LLC dba Sun Country Airlines Los Angeles District Office Interstate Conveyance Sanitation Regulations Not Issued *
July 21, 2010 Euro Gourmet, Inc. Baltimore District Office Seafood HACCP/Adulterated Not Issued *
September 25, 2009 Trans-Caribbean Dairy Corporation 9/25/09 San Juan District Office Juice HACCP/Adulterated Not Issued *
http://archpedi.ama-assn.org/cgi/collection/advice_for_patients
Archives of Pediatrics & Adolescent Medicine Advice for Patients
Division of High-Consequence Pathogens and Pathology (DHCPP)
http://www.cdc.gov/ncezid/dhcpp/index.html
Graco Recalls Quattro™ and MetroLite™ Strollers Due to Risk of Entrapment and Strangulation
http://www.cpsc.gov/cpscpub/prerel/prhtml11/11015.html
Four Infant Strangulation Deaths Reported
Wednesday, October 20, 2010
Friday, October 15, 2010
Public service advisory re Rustans stores in Makati, Manila, Mandaluyong. When I wrote to said stores asking for proofs, if any, that cosmetics they sell really contain the products they were advertised to contain and provide the benefits they were advertised as allegedly providing, said stores either did not provide me with a reply, or referred me somewhere else, or provided me with a brochure regarding said product. Security lapse on or about July 18, 2010, at entrance to Rustans store at Ayala Center, Makati.The guard at said entrance didn't inspect my luggage or subject my luggage to scanning with metal detector. Said luggage was large enough to contain grenades and firearms. Then the employee, at what was identified as the package counter of said store, accepted said luggage without first inspecting said luggage or subjecting said luggage to scanning with metal detector. I have a piece of paper said employee signed as proof he received said luggage.
lax security at Rustan's San Antonio, Makati
On September 12, 2010, nobody at the entrance to Rustan's San Antonio, Makati, inspected my shoulder bag or subjected said bag to scanning with metal detector. Said bag was large enough to contain a grenade or a firearm. The image below is of the receipt issued to me by said store. Also, while I was at said store, I inspected the whole customer area of said store and there was no visible required express lane for senior citizens and no visible required sign regarding the privileges of senior citizens. I believe the management of said store violated the implementing rules and regulations of the Expanded Senior Citizens Act of 2003.
Lax security at Glorietta, Ayala Center, Makati
On October 14, 2010, the guard at an entrance to said building, didn't inspect the contents of my luggage/subject said luggage to scanning with metal detector. Said luggage was large enough to contain grenades and firearms. Said entrance was beside Mercury Drug store. After entering said building, I bought food from what was identified as McDonald's Glorietta 3. I was given an official receipt dated 14/10/2010.
http://www.savingadvice.com/
savingadvice com web site
http://emedicine.medscape.com/
emedicine medscape com web site
Prohibited Items for travelers
http://www.tsa.gov/travelers/airtravel/prohibited/permitted-prohibited-items.shtm
Fire Hazard Prompts Canon U.S.A. to Recall Previous Model Desktop Copiers for Repair
http://www.cpsc.gov/cpscpub/prerel/prhtml06/06259.html
Safe Travel with Batteries and Devices
http://www.tsa.gov/travelers/airtravel/assistant/batteries.shtm
http://safetravel.dot.gov/
SafeTravel dot gov web site
| Home | Batteries | Aerosols | Ammunition | Lighters & Matches
| Fireworks | Self-Defense Spray | Media | Contact | Accessibility
Welcome to SafeTravel.dot.gov, your source for tips to help travelers get to their destinations quickly and safely!
SafeTravel involves more than government regulations, including giving travelers the best advice and expertise of interested parties within the travel industry, as well as within government.
So even if your travel plans are technically within U.S. DOT regulations, SafeTravel aims to bring you safe practices to employ when packing and traveling.
And that means fewer delays for the traveling public, and many, many more incident-free trips!
Spare battery tips
http://safetravel.dot.gov/tips.html
Traveling Safely with BATTERIES AND BATTERY-POWERED DEVICES
ALWAYS REMEMBER
http://safetravel.dot.gov/remember.html
Child injuries are preventable
http://www.cdc.gov/safechild/Fact_Sheets/Falls-Fact-Sheet-a.pdf "Public Playground Safety Handbook"
http://www.cpsc.gov/cpscpub/pubs/325.pdf
publication "Public Playground Safety Handbook"
http://www.cpsc.gov/cpscpub/pubs/325.pdf
http://www.cpsc.gov/onsafety/
U.S. government Consumer Product Safety Commission web site onsafety section
http://www.xe.com/ucc/
currency converter web site
lax security at Rustan's San Antonio, Makati
On September 12, 2010, nobody at the entrance to Rustan's San Antonio, Makati, inspected my shoulder bag or subjected said bag to scanning with metal detector. Said bag was large enough to contain a grenade or a firearm. The image below is of the receipt issued to me by said store. Also, while I was at said store, I inspected the whole customer area of said store and there was no visible required express lane for senior citizens and no visible required sign regarding the privileges of senior citizens. I believe the management of said store violated the implementing rules and regulations of the Expanded Senior Citizens Act of 2003.
Lax security at Glorietta, Ayala Center, Makati
On October 14, 2010, the guard at an entrance to said building, didn't inspect the contents of my luggage/subject said luggage to scanning with metal detector. Said luggage was large enough to contain grenades and firearms. Said entrance was beside Mercury Drug store. After entering said building, I bought food from what was identified as McDonald's Glorietta 3. I was given an official receipt dated 14/10/2010.
http://www.savingadvice.com/
savingadvice com web site
http://emedicine.medscape.com/
emedicine medscape com web site
Prohibited Items for travelers
http://www.tsa.gov/travelers/airtravel/prohibited/permitted-prohibited-items.shtm
Fire Hazard Prompts Canon U.S.A. to Recall Previous Model Desktop Copiers for Repair
http://www.cpsc.gov/cpscpub/prerel/prhtml06/06259.html
Safe Travel with Batteries and Devices
http://www.tsa.gov/travelers/airtravel/assistant/batteries.shtm
http://safetravel.dot.gov/
SafeTravel dot gov web site
| Home | Batteries | Aerosols | Ammunition | Lighters & Matches
| Fireworks | Self-Defense Spray | Media | Contact | Accessibility
Welcome to SafeTravel.dot.gov, your source for tips to help travelers get to their destinations quickly and safely!
SafeTravel involves more than government regulations, including giving travelers the best advice and expertise of interested parties within the travel industry, as well as within government.
So even if your travel plans are technically within U.S. DOT regulations, SafeTravel aims to bring you safe practices to employ when packing and traveling.
And that means fewer delays for the traveling public, and many, many more incident-free trips!
Spare battery tips
http://safetravel.dot.gov/tips.html
Traveling Safely with BATTERIES AND BATTERY-POWERED DEVICES
ALWAYS REMEMBER
http://safetravel.dot.gov/remember.html
Child injuries are preventable
http://www.cdc.gov/safechild/Fact_Sheets/Falls-Fact-Sheet-a.pdf "Public Playground Safety Handbook"
http://www.cpsc.gov/cpscpub/pubs/325.pdf
publication "Public Playground Safety Handbook"
http://www.cpsc.gov/cpscpub/pubs/325.pdf
http://www.cpsc.gov/onsafety/
U.S. government Consumer Product Safety Commission web site onsafety section
http://www.xe.com/ucc/
currency converter web site
Saturday, October 9, 2010
October 6, 2010
Nobody at entrance to Harrison Plaza inspected my luggage/subjected said luggage to scanning with metal detector. Said luggage was large enough to contain grenades and firearms. After entering said building, I went to Shopwise store.
Nobody at entrance to said store inspected my bag/subjected said luggage to scanning with metal detector. Said bag was large enough to contain firearm. Said store sold me a imported Frito Lay branded potato chips without visible
name and address of the importer of said product. While I was at said store, I didn't see a required express lane for senior citizens. I also didn't see a sign, etc. re privileges of senior citizens. I saw eggs for sale which were not
refrigerated.
http://www.articlesbase.com/
articlesbase web site
National Institute of Neurological Disorders and Stroke
http://www.ninds.nih.gov/disorders/disorder_index.htm
Disorder Index
ready gov web site
http://www.ready.gov/
http://en.allexperts.com/
en allexperts com web site
Learn to Stay Safe from Home Fires
http://www.cdc.gov/Features/FirePrevention/
Learn how you can make your home a safer place for you and your family. You can prevent home fires.
The Risk is Real
The risk of injury and death from home fires is real.
Keep Your Home Fire Safe
Your home should be a safe and comfortable place—and you can help keep it fire-safe by following these prevention tips.
Cook with care. When you cook, never leave cooking food unattended on the stove. Keep anything that can catch on fire, like potholders and towels, away from the cooking area. Avoid wearing clothes with long, loose-fitting sleeves that can catch on fire. Also, keep pot handles turned in.
If you smoke, attempt to quit. Don't smoke inside your home. If you do smoke in your home, never smoke in bed or leave burning cigarettes unattended. It is unsafe to smoke while drowsy or under the influence of alcohol or medications. Also, don't empty burning or hot ashes in a trash can, and keep ashtrays away from upholstered furniture and curtains.
Protect the Ones You Love
In an effort to raise parents' awareness about the leading causes of child injury—including burns— in the United States and how they can be prevented, CDC launched
the "Protect the Ones You Love" initiative. Parents can play a life-saving role in protecting children from injuries. Information is available in English and Spanish.
Learn more.
Stay warm—safely. If and when you use a space heater, keep it more than three feet away from anything that can catch on fire, like draperies.
Be alarmed. Install smoke alarms on every floor of your home, including the basement, and make sure you have smoke alarms near all sleeping rooms. For better protection, install smoke alarms in sleeping rooms, especially if they are occupied by a smoker. Test all smoke alarms once a month using the test button.
Make and practice an escape plan. Create a home fire escape plan. Know at least two ways out of every room, if possible, and have a meeting place outside. Practice
your escape plan twice a year with everyone living in your home.
For more tips on protecting children from burns, visit CDC's Protect the Ones You Love.
A Time to Act
An online video available through CDC-TV, "A Time to Act", chronicles the experience of a family that escaped during a home fire after being alerted by recently installed smoke alarms. The video also reviews the main risk factors for home fires and steps viewers can take to reduce the risk of fire-related injury and death. These steps include installing and regularly testing smoke alarms and practicing a fire escape plan at least twice a year.
"A Time to Act" is available for viewing through a number of channels including mobile phone, or as a podcast, or for download (see "Download this Video" instructions on the CDC-TV page) thus allowing organizations to utilize our online video in any number of ways including as an instructional tool for parents, healthcare providers or teachers. Providing short, high-quality videos is part of CDC's goal to increase people's access to the information necessary to help prevent illness, injury and to protect their health and that of their families.
More Information
CDC Resources
* CDC Fire Deaths and Injuries Fact Sheet
* Protect the Ones You Love: Burns
* Fire Spokesperson's Pocket Media Guide
* Listen to Podcasts on Fire and Burn Prevention:
o Protect the Ones You Love from Burns (English, 2008) [PODCAST - 2:58 minutes]
o Protect the Ones You Love from Burns (Spanish, 2008) [PODCAST - 3:16 minutes]
External Resources
* FireSafety.gov:External Web Site IconExternal Web Site Icon Information Resources for Eliminating Residential Fire DeathsExternal Web Site Icon
* Fire Prevention Week Information, National Fire Protection AssociationExternal Web Site Icon
* Fire Safety Publications, US Consumer Product Safety CommissionExternal Web Site Icon
National Heart Lung and Blood Institute web site
http://www.nhlbi.nih.gov/
http://www.populararticles.com/
popularticles com web site
Protect the Ones You Love
http://www.cdc.gov/safechild/index.html
safety com web site
http://safety.com
lax security on October 9, 2010 at Adriatico St. entrance to Robinsons Place Manila.The guard at said entrance didn't inspect my luggage. While I was in said building, I purchased food from Wendy's Hamburger restaurant and was issued Wendy's
Hamburger restaurant sales invoice No. 1539 dated 10/9/10.
online conversion web site
http://www.onlineconversion.com/
facts randomhistory com web site
http://facts.randomhistory.com/
forbes com web site
http://www.forbes.com/
NEW NATIONAL REFERENCE LAB
http://www.doh.gov.ph/
Asec Punzalan attended the ribbon-cutting of the the new NRLDepartment of Health Assistant Secretary Dr. Elmer Punzalan(left) and National Health Laboratory Network Overall Chairman Dr. Juanito Billote recently opened the Philippine Heart Center (PHC) Division of Laboratory Medicine as the latest addition to the DOH National Reference Laboratory. As a reference laboratory for pathology of cardiovascular diseases, the PHC now offers referral service for histopathology, special stains including special studies, gross dissection and examination, autopsy consultation for cardiovascular pathology and external quality assurance activities. The PHC-NRL also offers seminars/training workshops and can be reached at 925-2401 local 5143.
http://www.azshare.gov/
azshare gov web site
http://www.biography.com/
biography com web site
http://oem.bmj.com/
Occupational and environmental medicine
Burns Safety
http://www.cdc.gov/safechild/Burns/index.html
http://en.allexperts.com/
en allexperts com web site
Learn to Stay Safe from Home Fires
http://www.cdc.gov/Features/FirePrevention/
National Heart Lung and Blood Institute web site
http://www.nhlbi.nih.gov/
http://www.populararticles.com/
popularticles com web site
safety com web site
http://safety.com
Brain Basics: Know Your Brain
http://www.ninds.nih.gov/disorders/brain_basics/know_your_brain.htm
I received a letter dated September 28, 2010 from what was identified as the Civil Service Commission. Said letter was addressed to Manila Mayor Lim of Manila. Said letter contains the following words: ".. .we refer for . . . appropriate
action, the letter dated September 13, 2010 of M. Silva . . . relative to his complaint that Manila's City Health Department refused to receive his registered mail (dated April 25, 2010). We will appreciate your preferential action
on the matter . . . Please advise M. Silva of the action taken thereon."
I received a letter dated September 21, 2010 addressed to Mr. Hector R.R. Villanueva Postmaster General Philippine Postal Corporation. The source of said letter was identified as the Civil Service Commission. Said letter contains
the words:". .. we refer . . . for information and appropriate action, the .. . letter dated August 21, 2010 of M.Silva .. . relative to the alleged inaction by the Pasay City Central Post Office on his alleged missing registered
letter" Said letter was addressed to Vice President Binay. "We will appreciate your preferential attention on the matter .. ."
I received a letter from a source identified as from the Civil Service Commission addressed to Manila Mayor Lim. Said letter is dated September 21, 2010 and contains the following words: ". . . we refer, for information and
appropriate action, the attached open letter dated August 18, 2010 of M. Silva . . . relative to his/her request for information on the complete listing of medical equipment being used on Manila government hospitals. We will appreciate
your preferential attention on the matter . . . Please advise M. Silva of the action taken thereon . . ." Up to October 8, 2010, said Mayor Lim has not communicated with me regarding said matter.
I received from a source identified as the Civil Service Commission a letter dated July 29, 2010 and addressed to Manila Mayor Lim. Said letter contains the words: ".. . we refer, for your information and appropriate action, the attached open letter to you dated July 7, 2010 of M. Silva . . . relative to his request for information on
whether the city government has complied with Rule IX, Article 11 of Republic Act No. 9257, which reads as follows: "It is the responsibilty of the municpality/city through the Mayor to require all establishments covered by the Act to prominently display posters, stickers, and other notices that will generate public awareness of the rights and privileges of senior citizens and to ensure that the provisions of the Act are implemented to its fullest." "Moreover, he is requesting a listing of the agencies which had complied therein. We will appreciate your preferential attention on the matter . . . Please advise M. Silva of the action taken thereon . ." Up to October 8, 2010, said Lim has not provided me with verifiable information regarding said matter.
egarding said matter.
Nobody at entrance to Harrison Plaza inspected my luggage/subjected said luggage to scanning with metal detector. Said luggage was large enough to contain grenades and firearms. After entering said building, I went to Shopwise store.
Nobody at entrance to said store inspected my bag/subjected said luggage to scanning with metal detector. Said bag was large enough to contain firearm. Said store sold me a imported Frito Lay branded potato chips without visible
name and address of the importer of said product. While I was at said store, I didn't see a required express lane for senior citizens. I also didn't see a sign, etc. re privileges of senior citizens. I saw eggs for sale which were not
refrigerated.
http://www.articlesbase.com/
articlesbase web site
National Institute of Neurological Disorders and Stroke
http://www.ninds.nih.gov/disorders/disorder_index.htm
Disorder Index
ready gov web site
http://www.ready.gov/
http://en.allexperts.com/
en allexperts com web site
Learn to Stay Safe from Home Fires
http://www.cdc.gov/Features/FirePrevention/
Learn how you can make your home a safer place for you and your family. You can prevent home fires.
The Risk is Real
The risk of injury and death from home fires is real.
Keep Your Home Fire Safe
Your home should be a safe and comfortable place—and you can help keep it fire-safe by following these prevention tips.
Cook with care. When you cook, never leave cooking food unattended on the stove. Keep anything that can catch on fire, like potholders and towels, away from the cooking area. Avoid wearing clothes with long, loose-fitting sleeves that can catch on fire. Also, keep pot handles turned in.
If you smoke, attempt to quit. Don't smoke inside your home. If you do smoke in your home, never smoke in bed or leave burning cigarettes unattended. It is unsafe to smoke while drowsy or under the influence of alcohol or medications. Also, don't empty burning or hot ashes in a trash can, and keep ashtrays away from upholstered furniture and curtains.
Protect the Ones You Love
In an effort to raise parents' awareness about the leading causes of child injury—including burns— in the United States and how they can be prevented, CDC launched
the "Protect the Ones You Love" initiative. Parents can play a life-saving role in protecting children from injuries. Information is available in English and Spanish.
Learn more.
Stay warm—safely. If and when you use a space heater, keep it more than three feet away from anything that can catch on fire, like draperies.
Be alarmed. Install smoke alarms on every floor of your home, including the basement, and make sure you have smoke alarms near all sleeping rooms. For better protection, install smoke alarms in sleeping rooms, especially if they are occupied by a smoker. Test all smoke alarms once a month using the test button.
Make and practice an escape plan. Create a home fire escape plan. Know at least two ways out of every room, if possible, and have a meeting place outside. Practice
your escape plan twice a year with everyone living in your home.
For more tips on protecting children from burns, visit CDC's Protect the Ones You Love.
A Time to Act
An online video available through CDC-TV, "A Time to Act", chronicles the experience of a family that escaped during a home fire after being alerted by recently installed smoke alarms. The video also reviews the main risk factors for home fires and steps viewers can take to reduce the risk of fire-related injury and death. These steps include installing and regularly testing smoke alarms and practicing a fire escape plan at least twice a year.
"A Time to Act" is available for viewing through a number of channels including mobile phone, or as a podcast, or for download (see "Download this Video" instructions on the CDC-TV page) thus allowing organizations to utilize our online video in any number of ways including as an instructional tool for parents, healthcare providers or teachers. Providing short, high-quality videos is part of CDC's goal to increase people's access to the information necessary to help prevent illness, injury and to protect their health and that of their families.
More Information
CDC Resources
* CDC Fire Deaths and Injuries Fact Sheet
* Protect the Ones You Love: Burns
* Fire Spokesperson's Pocket Media Guide
* Listen to Podcasts on Fire and Burn Prevention:
o Protect the Ones You Love from Burns (English, 2008) [PODCAST - 2:58 minutes]
o Protect the Ones You Love from Burns (Spanish, 2008) [PODCAST - 3:16 minutes]
External Resources
* FireSafety.gov:External Web Site IconExternal Web Site Icon Information Resources for Eliminating Residential Fire DeathsExternal Web Site Icon
* Fire Prevention Week Information, National Fire Protection AssociationExternal Web Site Icon
* Fire Safety Publications, US Consumer Product Safety CommissionExternal Web Site Icon
National Heart Lung and Blood Institute web site
http://www.nhlbi.nih.gov/
http://www.populararticles.com/
popularticles com web site
Protect the Ones You Love
http://www.cdc.gov/safechild/index.html
safety com web site
http://safety.com
lax security on October 9, 2010 at Adriatico St. entrance to Robinsons Place Manila.The guard at said entrance didn't inspect my luggage. While I was in said building, I purchased food from Wendy's Hamburger restaurant and was issued Wendy's
Hamburger restaurant sales invoice No. 1539 dated 10/9/10.
online conversion web site
http://www.onlineconversion.com/
facts randomhistory com web site
http://facts.randomhistory.com/
forbes com web site
http://www.forbes.com/
NEW NATIONAL REFERENCE LAB
http://www.doh.gov.ph/
Asec Punzalan attended the ribbon-cutting of the the new NRLDepartment of Health Assistant Secretary Dr. Elmer Punzalan(left) and National Health Laboratory Network Overall Chairman Dr. Juanito Billote recently opened the Philippine Heart Center (PHC) Division of Laboratory Medicine as the latest addition to the DOH National Reference Laboratory. As a reference laboratory for pathology of cardiovascular diseases, the PHC now offers referral service for histopathology, special stains including special studies, gross dissection and examination, autopsy consultation for cardiovascular pathology and external quality assurance activities. The PHC-NRL also offers seminars/training workshops and can be reached at 925-2401 local 5143.
http://www.azshare.gov/
azshare gov web site
http://www.biography.com/
biography com web site
http://oem.bmj.com/
Occupational and environmental medicine
Burns Safety
http://www.cdc.gov/safechild/Burns/index.html
http://en.allexperts.com/
en allexperts com web site
Learn to Stay Safe from Home Fires
http://www.cdc.gov/Features/FirePrevention/
National Heart Lung and Blood Institute web site
http://www.nhlbi.nih.gov/
http://www.populararticles.com/
popularticles com web site
safety com web site
http://safety.com
Brain Basics: Know Your Brain
http://www.ninds.nih.gov/disorders/brain_basics/know_your_brain.htm
I received a letter dated September 28, 2010 from what was identified as the Civil Service Commission. Said letter was addressed to Manila Mayor Lim of Manila. Said letter contains the following words: ".. .we refer for . . . appropriate
action, the letter dated September 13, 2010 of M. Silva . . . relative to his complaint that Manila's City Health Department refused to receive his registered mail (dated April 25, 2010). We will appreciate your preferential action
on the matter . . . Please advise M. Silva of the action taken thereon."
I received a letter dated September 21, 2010 addressed to Mr. Hector R.R. Villanueva Postmaster General Philippine Postal Corporation. The source of said letter was identified as the Civil Service Commission. Said letter contains
the words:". .. we refer . . . for information and appropriate action, the .. . letter dated August 21, 2010 of M.Silva .. . relative to the alleged inaction by the Pasay City Central Post Office on his alleged missing registered
letter" Said letter was addressed to Vice President Binay. "We will appreciate your preferential attention on the matter .. ."
I received a letter from a source identified as from the Civil Service Commission addressed to Manila Mayor Lim. Said letter is dated September 21, 2010 and contains the following words: ". . . we refer, for information and
appropriate action, the attached open letter dated August 18, 2010 of M. Silva . . . relative to his/her request for information on the complete listing of medical equipment being used on Manila government hospitals. We will appreciate
your preferential attention on the matter . . . Please advise M. Silva of the action taken thereon . . ." Up to October 8, 2010, said Mayor Lim has not communicated with me regarding said matter.
I received from a source identified as the Civil Service Commission a letter dated July 29, 2010 and addressed to Manila Mayor Lim. Said letter contains the words: ".. . we refer, for your information and appropriate action, the attached open letter to you dated July 7, 2010 of M. Silva . . . relative to his request for information on
whether the city government has complied with Rule IX, Article 11 of Republic Act No. 9257, which reads as follows: "It is the responsibilty of the municpality/city through the Mayor to require all establishments covered by the Act to prominently display posters, stickers, and other notices that will generate public awareness of the rights and privileges of senior citizens and to ensure that the provisions of the Act are implemented to its fullest." "Moreover, he is requesting a listing of the agencies which had complied therein. We will appreciate your preferential attention on the matter . . . Please advise M. Silva of the action taken thereon . ." Up to October 8, 2010, said Lim has not provided me with verifiable information regarding said matter.
egarding said matter.
Monday, October 4, 2010
FDA Warning Letter to Johnson & Johnson
Johnson & Johnson Consumer Group of Companies, Inc. 9/27/10
Department of Health and Human Services' logoDepartment of Health and Human Services
Public Health Service
Food and Drug Administration
Waterview Corporate Center
10 Waterview Blvd., 3rd Floor
Parsippany, NJ 07054
Telephone (973) 331-4906
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm227362.htm
U.S. FDA warning letter to Johnson & Johnson
September 27, 2010
WARNING LETTER
HAND DELIVERED
Mark Bowden
Vice President of Global Regulatory Affairs
Johnson and Johnson Consumer Products, Inc.
199 Grandview Road
Skillman, New Jersey 08558-1303
10-NWJ-17
Dear Mr. Bowden:
This letter is in reference to the Listerine Total Care Anticavity Mouthwash distributed by your firm. The label for this product makes the following claims: "Strengthens Teeth, Restores Minerals to Enamel, Fights Unsightly Plaque Above the Gum Line, Helps Prevent Cavities, Kills Bad Breath Germs, and Freshens Breath."
Based on these labeled claims "Fights Unsightly Plaque Above the Gum Line" and "Prevents Cavities," Listerine Total Care Anticavity Mouthwash is a drug as defined in section 201(g) of the Federal Food, Drug, and Cosmetic Act (Act) (21 U.S.C. § 321(g)) because the product is intended for use in preventing or mitigating disease, or to affect the structure or function of the body, by preventing cavities and removing plaque. Sodium fluoride 0.0221% (0.01% w/v fluoride ion) for the purpose of "Anticavity" is the sole active ingredient listed for this product. This product is subject to the Final sole active ingredient listed for this product. This product is subject to the Final Monograph for Anticaries Drug Products for Over-the-Counter Use, 21 CFR Part 355, which covers the product's disease claim of helping "prevent cavities," and includes this active ingredient.
However, another claim on the label of Listerine Total Care Anticavity Mouthwash is "Fights Unsightly Plaque Above the Gum Line." This statement represents that the product fights plaque, a well-known precursor to gum disease, including gingivitis. Antiplaque/antigingivitis claims are not covered by the Anticaries Final Monograph. Such antiplaque/antigingivitis claims are, however, addressed in the Advanced Notice of Proposed Rulemaking (ANPR) for Oral Healthcare Products for antigingivitis/antiplaque (68 Fed. Reg. 32232 (May 29, 2003)). In that ANPR, the agency identified active ingredients under consideration for inclusion in an antigingivitis/antiplaque monograph; however, sodium fluoride is not among them.
Thus, no mouthwash with sodium fluoride as the active ingredient has been included or proposed for inclusion in any monograph for the antiplaque/antigingivitis indications claimed for Listerine Total Anti-cavity Mouthwash; that ingredient is not included among those under evaluation in the ANPR for antiplaque/antigingivitis drug products, nor does the anticaries monograph at 21 CFR part 355, which does include the active ingredient of sodium fluoride, include antiplaque claims as recognized claims. As formulated and labeled, Listerine Total Anticavity Mouthwash is not generally recognized as safe and effective for the antiplaque indications in its labeling, and it is, therefore, a new drug under section 201(P) of the Act (21 U.S.C. § 321 (P)). Under section 505(a) of the Act (21 U.S.C. § 355(a)), a new drug may not be introduced or delivered for introduction into interstate commerce unless it is the subject of an FDA-approved application. The marketing of Listerine Total Anticavity Mouthwash without an FDA-approved application violates this provision of the Act.
In addition, the front panel of your product states the product name: "Listerine Total Care Anticavity Mouthwash." The violative claims described in the above paragraphs, combined with the appearance of the "Total Care" name, suggests that the product is comprehensive in function, and will provide benefits, including antigingivitis and antiplaque benefits. We are not aware of any support for the antiplaque/antigingivitis claims or other statements suggesting that the product is comprehensive in function, providing benefits beyond those related to prevention of cavities. Thus, the product's labeling claim that it will provide all of the benefits listed, is misleading and accordingly makes it misbranded within the meaning of section 502(a) of the Act. (21 U.S.C. §352(a)).
The violations cited in this letter are not an all-inclusive list of deficiencies. You are responsible for investigating and determining the causes of these violations and for preventing their recurrence and the occurrence of other violations. You are to assure that your firm complies with all requirements of federal law and FDA regulations.
You should take prompt action to correct the violations cited in this letter. Failure to promptly correct these violations may result in legal action without further notice, including, without limitation, seizure and injunction. Other federal agencies may take this Warning Letter into account when considering the award of contracts.
We note additionally that your principal display panel (PDP) describes your product as "Sodium Fluoride and Acidulated Phosphate Topical Solution." The Drug Facts panel lists the sole active ingredient as "Sodium fluoride 0.0221% (0.01% fluoride ion)." These representations are inconsistent. Based on the information in your Drug Facts panel, it appears that the PDP should refer to either "Sodium Fluoride Acidulated Phosphate Solution" or just "Sodium Fluoride Solution." The Sodium fluoride listed in the drug facts panel should be listed at 0.02%; not 0.0221 %.
Within fifteen working days of receipt of this letter, please notify this office in writing of the specific steps that you have taken to correct the referenced violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you cannot complete corrective action within fifteen working days, state the reason for the delay and the time within which you will complete the correction. Your reply should be addressed to Robert J. Maffei, Compliance Officer, at the above address.
Sincerely,
/s/
DIANA AMADOR-TORO
District Director
New Jersey District Office
-
-
Links on this page:
Page Last Updated: 09/28/2010
http://www.goodnewsbroadcast.com/
goodnewsbroadcast web site
National Institute of Health site on bone health and osteoporosis
http://www.niams.nih.gov/Health_Info/Bone/default.asp
Pfizer Consumer Healthcare Issues Voluntary Recall of One Lot of ThermaCare HeatWraps Menstrual Product
http://www.fda.gov/Safety/Recalls/ucm227658.htm
FOR IMMEDIATE RELEASE – September 24, 2010 – Madison, NJ – Pfizer Consumer Healthcare, a business of Pfizer, Inc., announced today a voluntary recall of one lot of its ThermaCare HeatWraps Menstrual product distributed in the United States and Puerto Rico.
The company said it is taking this precautionary step after finding a potential for a leak of the components contained in the wrap, which could cause skin injury such as irritation or burn. The issue is limited to the recalled lot. No other ThermaCare products are impacted. Pfizer has notified the U.S. Food and Drug Administration.
The lot number of the products involved is:
Lot # Exp. Date Product Name
E06831 8/2012 ThermaCare HeatWraps Menstrual
This lot number is listed on both the outer carton and the foil pouch. The lot number may be followed by either an S or an N. For more information on the recall and where to find this information on the package please visit www.thermacare.com9 or call 1-800-323-3383, Monday through Friday, 9am to 5pm est.
Pfizer Consumer HealthCare is removing the product in question from store shelves and asking consumers who have purchased and are still in possession of the affected product to record the lot number, throw the product away in its entirety without opening the foil pouch, and call 1-800-323-3383 for replacement.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
* Online: www.fda.gov/medwatch/report.htm 10
* Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm11.
* Mail to MedWatch 5600 Fishers Lane, Rockville, MD 20852-9787
* Fax: 1-800-FDA-0178
Photos: Product Labels12
RSS Feed for FDA Recalls Information13 [what's this?14]
Links on this page:
1. /default.htm
2. /Safety/default.htm
3. /Safety/Recalls/default.htm
4. /Safety/Recalls/default.htm
5. /Safety/Recalls/ArchiveRecalls/default.htm
6. /Safety/Recalls/EnforcementReports/default.htm
7. /Safety/Recalls/IndustryGuidance/default.htm
8. /Safety/Recalls/MajorProductRecalls/default.htm
9. http://www.thermacare.com/
10. http://www.fda.gov/medwatch/report.htm
11. http://www.fda.gov/MedWatch/getforms.htm
12. /Safety/Recalls/ucm227676.htm
13. /AboutFDA/ContactFDA/StayInformed/RSSFeeds/Recalls/rss.xml
14. /AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm
Page Last Updated: 09/29/2010
Pertussis (Whooping Cough) – What You Need To Know
http://www.cdc.gov/Features/Pertussis/
Pfizer Consumer Healthcare Issues Voluntary Recall of One Lot of ThermaCare HeatWraps Menstrual Product
http://www.fda.gov/Safety/Recalls/ucm227658.htm
FOR IMMEDIATE RELEASE – September 24, 2010 – Madison, NJ – Pfizer Consumer Healthcare, a business of Pfizer, Inc., announced today a voluntary recall of one lot of its ThermaCare HeatWraps Menstrual product distributed in the United States and Puerto Rico.
The company said it is taking this precautionary step after finding a potential for a leak of the components contained in the wrap, which could cause skin injury such as irritation or burn. The issue is limited to the recalled lot. No other ThermaCare products are impacted. Pfizer has notified the U.S. Food and Drug Administration.
The lot number of the products involved is:
Lot # Exp. Date Product Name
E06831 8/2012 ThermaCare HeatWraps Menstrual
This lot number is listed on both the outer carton and the foil pouch. The lot number may be followed by either an S or an N. For more information on the recall and where to find this information on the package please visit www.thermacare.com9 or call 1-800-323-3383, Monday through Friday, 9am to 5pm est.
Pfizer Consumer HealthCare is removing the product in question from store shelves and asking consumers who have purchased and are still in possession of the affected product to record the lot number, throw the product away in its entirety without opening the foil pouch, and call 1-800-323-3383 for replacement.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
* Online: www.fda.gov/medwatch/report.htm 10
* Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm11.
* Mail to MedWatch 5600 Fishers Lane, Rockville, MD 20852-9787
* Fax: 1-800-FDA-0178
RSS Feed for FDA Recalls Information13 [what's this?14]
Links on this page:
1. /default.htm
2. /Safety/default.htm
3. /Safety/Recalls/default.htm
4. /Safety/Recalls/default.htm
5. /Safety/Recalls/ArchiveRecalls/default.htm
6. /Safety/Recalls/EnforcementReports/default.htm
7. /Safety/Recalls/IndustryGuidance/default.htm
8. /Safety/Recalls/MajorProductRecalls/default.htm
9. http://www.thermacare.com/
10. http://www.fda.gov/medwatch/report.htm
11. http://www.fda.gov/MedWatch/getforms.htm
12. /Safety/Recalls/ucm227676.htm
13. /AboutFDA/ContactFDA/StayInformed/RSSFeeds/Recalls/rss.xml
14. /AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm
Page Last Updated: 09/29/2010
Wonderful World MSNBC web site
http://www.msnbc.msn.com/id/13282721/
http://www.articlesbase.com/
articlesbase web site
FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm227796.htm
Thu, 30 Sep 2010 13:00:00 -0500
http://www.findhow.com
Fisher-Price Recalls
http://www.cpsc.gov/cpscpub/prerel/prerelsep10.html
Fisher-Price Recalls Infant Toys with Inflatable Balls Due to Choking Hazard
In cooperation with the U.S. Consumer Product Safety Commission and Health Canada, Fisher-Price Inc., of East Aurora, N.Y., is voluntarily recalling about 2.8 million Baby Playzone™ Crawl & Cruise Playgrounds™, Baby Playzone™ Crawl & Slide Arcades™ , Baby Gymtastics™ Play Wall, Ocean Wonders™ Kick & Crawl™ Aquarium (C3068 and H8094), 1-2-3 Tetherballs™, and Bat & Score Goals™ (in the United States and 125,000 in Canada). The valve of the inflatable ball on these toys can come off and pose a choking hazard to young children.
Fisher-Price Recalls Healthy Care, Easy Clean and Close to Me High Chairs Due to Laceration Hazard
In cooperation with the U.S. Consumer Product Safety Commission and Health Canada, Fisher-Price Inc., of East Aurora, N.Y., is voluntarily recalling about 950,000 Healthy Care, Easy Clean and Close to Me High Chairs (in the United States and 125,000 in Canada). Children can fall on or against the pegs on the rear legs of the high chair resulting in injuries or lacerations. The pegs are used for high chair tray storage.
Fisher-Price Recalls Little People Wheelies Stand 'n Play Rampway Due to Choking Hazard
In cooperation with the U.S. Consumer Product Safety Commission and Health Canada, Fisher-Price Inc., of East Aurora, N.Y., is voluntarily recalling about 100,000 Fisher-Price Little People Wheelies Stand 'n Play Rampways (in the United States and 20,000 in Canada). The wheels on the purple and the green cars can come off, posing a choking hazard to young children.
Fisher-Price Recalls Children's Trikes Due to Risk of Serious Injury
In cooperation with the U.S. Consumer Product Safety Commission and Health Canada, Fisher-Price Inc., of East Aurora, N.Y., is voluntarily recalling about 7 Million Fisher Price Trikes and Tough Trikes toddler tricycles (in the United States and 150,000 in Canada). A child can strike, sit or fall on the protruding plastic ignition key resulting in serious injury, including genital bleeding
http://www.lightningsafety.noaa.gov/
National Weather Service
Check this site for handouts, indoor safety and outdoor risk reduction tips, medical facts, history, survivor stories, photos, teacher tools, kids page and more.
Sepsis
http://www.nlm.nih.gov/medlineplus/sepsis.html
http://www.smartertravel.com/
smartertravel web site
U,S. FDA Enforcement Report for September 29, 2010
http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm227948.htm
RECALLS AND FIELD CORRECTIONS: FOODS - CLASS I
FDA Orders Most Colchicine Products Off the Market
http://www.medpagetoday.com/PublicHealthPolicy/FDAGeneral/22506
Brain Basics: Know Your Brain
http://www.ninds.nih.gov/disorders/brain_basics/know_your_brain.htm
flu gov web site
http://www.flu.gov/
foodtimeline web site
http://www.foodtimeline.org/index.html
ready gov web site
http://www.ready.gov/
Sprouts: What You Should Know
http://www.foodsafety.gov/keep/types/fruits/sprouts.htmlDo sprouts carry a risk of illness? Like any fresh produce that is consumed raw or lightly cooked, sprouts carry a risk of foodborne illness. Unlike other fresh produce, seeds and beans need warm and humid conditions to sprout and grow. These conditions are also ideal for the growth of bacteria, including Salmonella, Listeria, and E. coli.
On September 30, 2010, while I was at Pancake House, Inc. at Level 4, Robinsons Place, Ermita, Manila, I didn't see required express lane for senior citizens in the customer area of said restaurant. I also didn't see, in the customer area of said restaurant, sign, etc. regarding privileges of senior citizens. Front line employee at said restaurant didn't have health certificate attached in the proper position on the clothing she was wearing. Proof of purchase is said restaurant's official receipt No. 1761 dated Sept. 30, 2010.
Bureau of Foods and Drugs ignored referral letter from DTI?
Based on evidence, a " Asst. Sec, Ma.Theresa "Angel" Pelayo National Capital Region Regional Operations Group" wrote a referral letter addressed to DIR Leticia
Barbara B. Gutierrez, of said bureau and dated December 23, 2008. Said letter contained the following words: ". . . referred . . . the herein attached two (2)
advisories from . . . M. Silva . . . relative to personal care creams, as the subject items/products fall within the jurisdiction that office. Action on the above
subject may be directly communicated to the complainant . . ." Up to October 3, 2010, said Bureau has not communicated with me regarding said advisories.
customer advisory vs. Star Appliance Center, Inc.
which was at SM Appliance Center, SM Makati Annex Bldg., Ayala Center, Makati.
On April 08, 2010, said firm required me to pay in advance, Philippine pesos 500, for installation by Ramecon Industries Corporation, of a room type air conditioner.
Proof of said payment is a copy of SM Appliance Center sales invoice with the above date and numbered 12251. The installation by said Ramecon Industries was not done
properly. For approximately 14 days after said installation, every time I turned on said air conditioner, excessive sound emanated from the vicinity of said air conditioner. The address of said Ramecon Industries Corporation was: 2300 Aurora Blvd., Pasay City.
St. Luke's Medical Center ignored DTI?
I have a letter dated June 2, 2009 identified as from the Department of Trade and Industry addressed to St. Luke's Medical Center in Quezon City. Said letter contains the words: "
. . . we refer to you the attached self-explanatory letter of concern from . . . M. Silva of 757 J.P. Rizal St., Makati City regarding various services and facilities
available/offered by your establishment. Information and assistance with the action taken thereon may be directly coordinated to Mr. Silva." Up to October 2, 2010,
Said establishment has not communicated with me regarding said letter.
Johnson & Johnson Consumer Group of Companies, Inc. 9/27/10
Department of Health and Human Services' logoDepartment of Health and Human Services
Public Health Service
Food and Drug Administration
Waterview Corporate Center
10 Waterview Blvd., 3rd Floor
Parsippany, NJ 07054
Telephone (973) 331-4906
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm227362.htm
U.S. FDA warning letter to Johnson & Johnson
September 27, 2010
WARNING LETTER
HAND DELIVERED
Mark Bowden
Vice President of Global Regulatory Affairs
Johnson and Johnson Consumer Products, Inc.
199 Grandview Road
Skillman, New Jersey 08558-1303
10-NWJ-17
Dear Mr. Bowden:
This letter is in reference to the Listerine Total Care Anticavity Mouthwash distributed by your firm. The label for this product makes the following claims: "Strengthens Teeth, Restores Minerals to Enamel, Fights Unsightly Plaque Above the Gum Line, Helps Prevent Cavities, Kills Bad Breath Germs, and Freshens Breath."
Based on these labeled claims "Fights Unsightly Plaque Above the Gum Line" and "Prevents Cavities," Listerine Total Care Anticavity Mouthwash is a drug as defined in section 201(g) of the Federal Food, Drug, and Cosmetic Act (Act) (21 U.S.C. § 321(g)) because the product is intended for use in preventing or mitigating disease, or to affect the structure or function of the body, by preventing cavities and removing plaque. Sodium fluoride 0.0221% (0.01% w/v fluoride ion) for the purpose of "Anticavity" is the sole active ingredient listed for this product. This product is subject to the Final sole active ingredient listed for this product. This product is subject to the Final Monograph for Anticaries Drug Products for Over-the-Counter Use, 21 CFR Part 355, which covers the product's disease claim of helping "prevent cavities," and includes this active ingredient.
However, another claim on the label of Listerine Total Care Anticavity Mouthwash is "Fights Unsightly Plaque Above the Gum Line." This statement represents that the product fights plaque, a well-known precursor to gum disease, including gingivitis. Antiplaque/antigingivitis claims are not covered by the Anticaries Final Monograph. Such antiplaque/antigingivitis claims are, however, addressed in the Advanced Notice of Proposed Rulemaking (ANPR) for Oral Healthcare Products for antigingivitis/antiplaque (68 Fed. Reg. 32232 (May 29, 2003)). In that ANPR, the agency identified active ingredients under consideration for inclusion in an antigingivitis/antiplaque monograph; however, sodium fluoride is not among them.
Thus, no mouthwash with sodium fluoride as the active ingredient has been included or proposed for inclusion in any monograph for the antiplaque/antigingivitis indications claimed for Listerine Total Anti-cavity Mouthwash; that ingredient is not included among those under evaluation in the ANPR for antiplaque/antigingivitis drug products, nor does the anticaries monograph at 21 CFR part 355, which does include the active ingredient of sodium fluoride, include antiplaque claims as recognized claims. As formulated and labeled, Listerine Total Anticavity Mouthwash is not generally recognized as safe and effective for the antiplaque indications in its labeling, and it is, therefore, a new drug under section 201(P) of the Act (21 U.S.C. § 321 (P)). Under section 505(a) of the Act (21 U.S.C. § 355(a)), a new drug may not be introduced or delivered for introduction into interstate commerce unless it is the subject of an FDA-approved application. The marketing of Listerine Total Anticavity Mouthwash without an FDA-approved application violates this provision of the Act.
In addition, the front panel of your product states the product name: "Listerine Total Care Anticavity Mouthwash." The violative claims described in the above paragraphs, combined with the appearance of the "Total Care" name, suggests that the product is comprehensive in function, and will provide benefits, including antigingivitis and antiplaque benefits. We are not aware of any support for the antiplaque/antigingivitis claims or other statements suggesting that the product is comprehensive in function, providing benefits beyond those related to prevention of cavities. Thus, the product's labeling claim that it will provide all of the benefits listed, is misleading and accordingly makes it misbranded within the meaning of section 502(a) of the Act. (21 U.S.C. §352(a)).
The violations cited in this letter are not an all-inclusive list of deficiencies. You are responsible for investigating and determining the causes of these violations and for preventing their recurrence and the occurrence of other violations. You are to assure that your firm complies with all requirements of federal law and FDA regulations.
You should take prompt action to correct the violations cited in this letter. Failure to promptly correct these violations may result in legal action without further notice, including, without limitation, seizure and injunction. Other federal agencies may take this Warning Letter into account when considering the award of contracts.
We note additionally that your principal display panel (PDP) describes your product as "Sodium Fluoride and Acidulated Phosphate Topical Solution." The Drug Facts panel lists the sole active ingredient as "Sodium fluoride 0.0221% (0.01% fluoride ion)." These representations are inconsistent. Based on the information in your Drug Facts panel, it appears that the PDP should refer to either "Sodium Fluoride Acidulated Phosphate Solution" or just "Sodium Fluoride Solution." The Sodium fluoride listed in the drug facts panel should be listed at 0.02%; not 0.0221 %.
Within fifteen working days of receipt of this letter, please notify this office in writing of the specific steps that you have taken to correct the referenced violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you cannot complete corrective action within fifteen working days, state the reason for the delay and the time within which you will complete the correction. Your reply should be addressed to Robert J. Maffei, Compliance Officer, at the above address.
Sincerely,
/s/
DIANA AMADOR-TORO
District Director
New Jersey District Office
-
-
Links on this page:
Page Last Updated: 09/28/2010
http://www.goodnewsbroadcast.com/
goodnewsbroadcast web site
National Institute of Health site on bone health and osteoporosis
http://www.niams.nih.gov/Health_Info/Bone/default.asp
Pfizer Consumer Healthcare Issues Voluntary Recall of One Lot of ThermaCare HeatWraps Menstrual Product
http://www.fda.gov/Safety/Recalls/ucm227658.htm
FOR IMMEDIATE RELEASE – September 24, 2010 – Madison, NJ – Pfizer Consumer Healthcare, a business of Pfizer, Inc., announced today a voluntary recall of one lot of its ThermaCare HeatWraps Menstrual product distributed in the United States and Puerto Rico.
The company said it is taking this precautionary step after finding a potential for a leak of the components contained in the wrap, which could cause skin injury such as irritation or burn. The issue is limited to the recalled lot. No other ThermaCare products are impacted. Pfizer has notified the U.S. Food and Drug Administration.
The lot number of the products involved is:
Lot # Exp. Date Product Name
E06831 8/2012 ThermaCare HeatWraps Menstrual
This lot number is listed on both the outer carton and the foil pouch. The lot number may be followed by either an S or an N. For more information on the recall and where to find this information on the package please visit www.thermacare.com9 or call 1-800-323-3383, Monday through Friday, 9am to 5pm est.
Pfizer Consumer HealthCare is removing the product in question from store shelves and asking consumers who have purchased and are still in possession of the affected product to record the lot number, throw the product away in its entirety without opening the foil pouch, and call 1-800-323-3383 for replacement.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
* Online: www.fda.gov/medwatch/report.htm 10
* Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm11.
* Mail to MedWatch 5600 Fishers Lane, Rockville, MD 20852-9787
* Fax: 1-800-FDA-0178
Photos: Product Labels12
RSS Feed for FDA Recalls Information13 [what's this?14]
Links on this page:
1. /default.htm
2. /Safety/default.htm
3. /Safety/Recalls/default.htm
4. /Safety/Recalls/default.htm
5. /Safety/Recalls/ArchiveRecalls/default.htm
6. /Safety/Recalls/EnforcementReports/default.htm
7. /Safety/Recalls/IndustryGuidance/default.htm
8. /Safety/Recalls/MajorProductRecalls/default.htm
9. http://www.thermacare.com/
10. http://www.fda.gov/medwatch/report.htm
11. http://www.fda.gov/MedWatch/getforms.htm
12. /Safety/Recalls/ucm227676.htm
13. /AboutFDA/ContactFDA/StayInformed/RSSFeeds/Recalls/rss.xml
14. /AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm
Page Last Updated: 09/29/2010
Pertussis (Whooping Cough) – What You Need To Know
http://www.cdc.gov/Features/Pertussis/
Pfizer Consumer Healthcare Issues Voluntary Recall of One Lot of ThermaCare HeatWraps Menstrual Product
http://www.fda.gov/Safety/Recalls/ucm227658.htm
FOR IMMEDIATE RELEASE – September 24, 2010 – Madison, NJ – Pfizer Consumer Healthcare, a business of Pfizer, Inc., announced today a voluntary recall of one lot of its ThermaCare HeatWraps Menstrual product distributed in the United States and Puerto Rico.
The company said it is taking this precautionary step after finding a potential for a leak of the components contained in the wrap, which could cause skin injury such as irritation or burn. The issue is limited to the recalled lot. No other ThermaCare products are impacted. Pfizer has notified the U.S. Food and Drug Administration.
The lot number of the products involved is:
Lot # Exp. Date Product Name
E06831 8/2012 ThermaCare HeatWraps Menstrual
This lot number is listed on both the outer carton and the foil pouch. The lot number may be followed by either an S or an N. For more information on the recall and where to find this information on the package please visit www.thermacare.com9 or call 1-800-323-3383, Monday through Friday, 9am to 5pm est.
Pfizer Consumer HealthCare is removing the product in question from store shelves and asking consumers who have purchased and are still in possession of the affected product to record the lot number, throw the product away in its entirety without opening the foil pouch, and call 1-800-323-3383 for replacement.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
* Online: www.fda.gov/medwatch/report.htm 10
* Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm11.
* Mail to MedWatch 5600 Fishers Lane, Rockville, MD 20852-9787
* Fax: 1-800-FDA-0178
RSS Feed for FDA Recalls Information13 [what's this?14]
Links on this page:
1. /default.htm
2. /Safety/default.htm
3. /Safety/Recalls/default.htm
4. /Safety/Recalls/default.htm
5. /Safety/Recalls/ArchiveRecalls/default.htm
6. /Safety/Recalls/EnforcementReports/default.htm
7. /Safety/Recalls/IndustryGuidance/default.htm
8. /Safety/Recalls/MajorProductRecalls/default.htm
9. http://www.thermacare.com/
10. http://www.fda.gov/medwatch/report.htm
11. http://www.fda.gov/MedWatch/getforms.htm
12. /Safety/Recalls/ucm227676.htm
13. /AboutFDA/ContactFDA/StayInformed/RSSFeeds/Recalls/rss.xml
14. /AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm
Page Last Updated: 09/29/2010
Wonderful World MSNBC web site
http://www.msnbc.msn.com/id/13282721/
http://www.articlesbase.com/
articlesbase web site
FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm227796.htm
Thu, 30 Sep 2010 13:00:00 -0500
http://www.findhow.com
Fisher-Price Recalls
http://www.cpsc.gov/cpscpub/prerel/prerelsep10.html
Fisher-Price Recalls Infant Toys with Inflatable Balls Due to Choking Hazard
In cooperation with the U.S. Consumer Product Safety Commission and Health Canada, Fisher-Price Inc., of East Aurora, N.Y., is voluntarily recalling about 2.8 million Baby Playzone™ Crawl & Cruise Playgrounds™, Baby Playzone™ Crawl & Slide Arcades™ , Baby Gymtastics™ Play Wall, Ocean Wonders™ Kick & Crawl™ Aquarium (C3068 and H8094), 1-2-3 Tetherballs™, and Bat & Score Goals™ (in the United States and 125,000 in Canada). The valve of the inflatable ball on these toys can come off and pose a choking hazard to young children.
Fisher-Price Recalls Healthy Care, Easy Clean and Close to Me High Chairs Due to Laceration Hazard
In cooperation with the U.S. Consumer Product Safety Commission and Health Canada, Fisher-Price Inc., of East Aurora, N.Y., is voluntarily recalling about 950,000 Healthy Care, Easy Clean and Close to Me High Chairs (in the United States and 125,000 in Canada). Children can fall on or against the pegs on the rear legs of the high chair resulting in injuries or lacerations. The pegs are used for high chair tray storage.
Fisher-Price Recalls Little People Wheelies Stand 'n Play Rampway Due to Choking Hazard
In cooperation with the U.S. Consumer Product Safety Commission and Health Canada, Fisher-Price Inc., of East Aurora, N.Y., is voluntarily recalling about 100,000 Fisher-Price Little People Wheelies Stand 'n Play Rampways (in the United States and 20,000 in Canada). The wheels on the purple and the green cars can come off, posing a choking hazard to young children.
Fisher-Price Recalls Children's Trikes Due to Risk of Serious Injury
In cooperation with the U.S. Consumer Product Safety Commission and Health Canada, Fisher-Price Inc., of East Aurora, N.Y., is voluntarily recalling about 7 Million Fisher Price Trikes and Tough Trikes toddler tricycles (in the United States and 150,000 in Canada). A child can strike, sit or fall on the protruding plastic ignition key resulting in serious injury, including genital bleeding
http://www.lightningsafety.noaa.gov/
National Weather Service
Check this site for handouts, indoor safety and outdoor risk reduction tips, medical facts, history, survivor stories, photos, teacher tools, kids page and more.
Sepsis
http://www.nlm.nih.gov/medlineplus/sepsis.html
http://www.smartertravel.com/
smartertravel web site
U,S. FDA Enforcement Report for September 29, 2010
http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm227948.htm
RECALLS AND FIELD CORRECTIONS: FOODS - CLASS I
FDA Orders Most Colchicine Products Off the Market
http://www.medpagetoday.com/PublicHealthPolicy/FDAGeneral/22506
Brain Basics: Know Your Brain
http://www.ninds.nih.gov/disorders/brain_basics/know_your_brain.htm
flu gov web site
http://www.flu.gov/
foodtimeline web site
http://www.foodtimeline.org/index.html
ready gov web site
http://www.ready.gov/
Sprouts: What You Should Know
http://www.foodsafety.gov/keep/types/fruits/sprouts.htmlDo sprouts carry a risk of illness? Like any fresh produce that is consumed raw or lightly cooked, sprouts carry a risk of foodborne illness. Unlike other fresh produce, seeds and beans need warm and humid conditions to sprout and grow. These conditions are also ideal for the growth of bacteria, including Salmonella, Listeria, and E. coli.
On September 30, 2010, while I was at Pancake House, Inc. at Level 4, Robinsons Place, Ermita, Manila, I didn't see required express lane for senior citizens in the customer area of said restaurant. I also didn't see, in the customer area of said restaurant, sign, etc. regarding privileges of senior citizens. Front line employee at said restaurant didn't have health certificate attached in the proper position on the clothing she was wearing. Proof of purchase is said restaurant's official receipt No. 1761 dated Sept. 30, 2010.
Bureau of Foods and Drugs ignored referral letter from DTI?
Based on evidence, a " Asst. Sec, Ma.Theresa "Angel" Pelayo National Capital Region Regional Operations Group" wrote a referral letter addressed to DIR Leticia
Barbara B. Gutierrez, of said bureau and dated December 23, 2008. Said letter contained the following words: ". . . referred . . . the herein attached two (2)
advisories from . . . M. Silva . . . relative to personal care creams, as the subject items/products fall within the jurisdiction that office. Action on the above
subject may be directly communicated to the complainant . . ." Up to October 3, 2010, said Bureau has not communicated with me regarding said advisories.
customer advisory vs. Star Appliance Center, Inc.
which was at SM Appliance Center, SM Makati Annex Bldg., Ayala Center, Makati.
On April 08, 2010, said firm required me to pay in advance, Philippine pesos 500, for installation by Ramecon Industries Corporation, of a room type air conditioner.
Proof of said payment is a copy of SM Appliance Center sales invoice with the above date and numbered 12251. The installation by said Ramecon Industries was not done
properly. For approximately 14 days after said installation, every time I turned on said air conditioner, excessive sound emanated from the vicinity of said air conditioner. The address of said Ramecon Industries Corporation was: 2300 Aurora Blvd., Pasay City.
St. Luke's Medical Center ignored DTI?
I have a letter dated June 2, 2009 identified as from the Department of Trade and Industry addressed to St. Luke's Medical Center in Quezon City. Said letter contains the words: "
. . . we refer to you the attached self-explanatory letter of concern from . . . M. Silva of 757 J.P. Rizal St., Makati City regarding various services and facilities
available/offered by your establishment. Information and assistance with the action taken thereon may be directly coordinated to Mr. Silva." Up to October 2, 2010,
Said establishment has not communicated with me regarding said letter.
Saturday, September 25, 2010
Evidence vs. Food and Drug Administration
Based on the registry return receipt for my letter, designated as 6_29_10_4, said letter addressed to the Bureau of Food and Drug, was received on 05_07_2010 by the
Food and Drug Administration. Despite R.A. 6713, which said bureau is required to obey, up to September 17, 2010,
said bureau has not provided me with acknowledgment that it received said letter and has not informed me what it did with said letter.
http://www.bfad.gov.ph/cfc/pdf.cfm?pdfid=1473
FDA Circular No. 2010-015
Declaring the Identified Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or
Distribution
FDA approves pediatric use of chemical poisoning treatment
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225347.htm
facts random history web site
http://facts.randomhistory.com/
Nationwide Philhealth Registration Day
Philhealth Sabado - October 2PhilHealth Sabado (October 2, 2010) is the start of a continuing advocacy program to increase awareness and knowledge of every Filipino on the importance of becoming a PhilHealth member that will ensure access to quality health services to the member and his/her dependents.
http://www.doh.gov.ph/node/2804.html
The program intends the registration of non-member informal sector under the individually paying program (IPP). It also provides for an opportunity to automatically register and distribute PhilHealth cards to about 800,000 indigents identified in the National Household Targeting System (NHTS) of the Department of Social Welfare and Development (DSWD).
PhilHealth Sabado fullfill universal health insurance coverage within three years as promised in the first State of the Nation Address of President Benigno S. Aquino III.
1. Paraan ng Pagpaparehistro
2. Paraan ng Paggamit
- Sponsored Program Members
- Individually Paying Members
3. Alamin ang Inyong Benepisyo
4. Frequently Asked Questions
PRESENTATIONS
1. National Philhealth Registration Day
2. National Philhealth Registration Day - Communication Plan
3. Dry-Run of the National Philhealth Registration Day
4. NPRD Joint Agreement
FDA issues new dosing guidance for children using Valcyte
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225887.htm
For Immediate Release: Sept. 15, 2010
Media Inquiries: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
Updated drug label will help prevent potential overdose in underweight transplant patients
The U.S. Food and Drug Administration is notifying health care professionals of updated dosing recommendations for Valcyte (valganciclovir) oral tablets and solution used by children and adolescents receiving a kidney or heart transplant. The update is intended to prevent drug overdosing of children with low body weight, low body surface area, and very low serum creatinine. The revised dosing instructions now appear in the product’s label.
The revised pediatric dosing recommendations now include an upper limit on “calculated creatinine clearance,” a measurement of kidney function. Creatinine is a waste product produced by the body during energy production and is eliminated by the kidneys.
Creatinine levels in the blood are used to estimate how well kidneys are functioning. High creatinine levels may signal poor kidney function, while low creatinine levels may be observed in patients who are not muscular.
Valcyte is an antiviral medication that can be effective for the prevention of cytomegalovirus (CMV) disease in children from 4 months to 16 years of age who have undergone a kidney or heart transplant and who are at a higher risk of getting the disease. CMV is a virus that can cause severe disease such as pneumonia or colitis in people with weakened immune systems, including organ transplant patients.
People using the medication should speak with their health care professional if they have questions about their Valcyte dose.
The medication is also approved to treat CMV retinitis (when the virus infects the eyes) in adults who have acquired immunodeficiency syndrome (AIDS) and is used to prevent CMV disease in people who have received a heart, kidney, or kidney-pancreas transplant with a high risk of getting CMV disease.
Valcyte is manufactured by San Francisco-based Genentech, a member of the Roche Group.
For more information:
Valcyte Drug Safety Communication
http://www.fda.gov/Drugs/DrugSafety/ucm225727.htm
#
RSS Feed for FDA News Releases [what is RSS?]
-
-
Links on this page:
1. http://www.fda.gov/MedWatch/report.htm
2. http://www.fda.gov/MedWatch/getforms.htm
3. http://www.fda.gov/Drugs/DrugSafety/ucm225727.htm
4. http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/PressReleases/rss.xml
5. http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/ucm144575.htm
Page Last Updated: 09/15/2010
http://ocw.mit.edu/index.htm
free online course materials Massachusetts Institute of Technology
The Cost of Flooding
http://www.floodsmart.gov/floodsmart/pages/flooding_flood_risks/the_cost_of_flooding.jsp
All it takes is a few inches of water to cause major damage to your home and its contents. This interactive tool shows you what a flood to your home could cost,
inch by inch.
Manila Health Department refused to accept letter?
I sent a letter to the Manila Health Department. Said letter was designated as registered letter No. 1889. Said letter was mailed on April 25, 2010.
I received back said letter.Based on the marking on the said envelope, said department refused to accept said letter.
Food and Drug Administration Philippines News and Announcements
News and Announcements
DOH_FDA_ADVISORY_2010-010: Product Recall Order For Alactagrow Bibo Trio Milk Supplement Covered by Registration No. FR-71538
DOH_FDA_ADVISORY_2010-009: Product Recall Order of Sustagen Junior Milk Drink Powder Vanilla Flavor (For 1-3 Years Old) Covered by Registration Number FR-72110
FDAC 2010-015: Declaring the Identified Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution
PNS/FDA 27:2010: Recommended Code of Practice for the Processing and Handling of Smoked Fish
PNS/FDA 26:2010: Smoked Fish - Specification
PNS/FDA 25:2010: Recommended Code of Practice for the Processing and Handling of Purple Yam (Ube) Jam (Halaya)
PNS/FDA 24:2010: Purple Yam (Ube) Jam (Halaya) - Specification
PNS/BFAD 29:2010: Recommended Code of Practice for the Processing and Handling of Processed Pili Nut Products
PNS/BFAD 28:2010: Processed Pili Nut Products - Specification
PNS/BFAD 23:2010: Recommended Code of Practice for the Processing and Handling of Fried Corn Snacks (Chichacorn)
PNS/BFAD 22:2010: Fried Corn Snacks (Chichacorn) - Specification
ASEAN Current Good Manufacturing Practice (cGMP) on Cosmetics
Paunawa mula sa DOH-FDA Blg. 2010-007: Babala sa Publiko Tungkol sa mga Produktong Herbal na Walang Label
FDAC 2010-011: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
Transplant Experts Commend DOH Issuance of AO on Deceased Donors Program
DOH Issues Administrative Order on Deceased Organ Donors
Statement of the Food and Drug Administration
DOH Mahalagang Paalala: Ang Food/Dietary Supplements ay HINDI GAMOT...........
FDA Circular No. 2010-009: Amendment to Memorandum Circular No. 05 series of 1994 regarding Reports on Adversed Drug Reaction
FDA Circular No. 2010-008: Adoption of the CODEX Standards of Food Contaminants in Processed Foods
DOH-FDA Advisory 2010-006: Reported Recall of Certain Infant and Children and Over-the-Counter Products Manufactured in the United States
FDA Advisory No. 2010-005: Rotarix Vaccine
FDA Advisory No. 2010-004: FDA Findings on Wheat Flour Imported from Turkey
AO 2010-0008: Directive Specific to the Change in the Use of the Phrase "No Approved Therapeutic Claim" in all Advertisement, Promotional, and/or Sponsorship Activities or Materials concerning Food/Dietary Supplements.
FDA Circular No. 2010-004: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
FDA Advisory 2010-003: Zhen De Shou Fat Loss Capsule and Zhen De Shou Fat Loss Tea
FDA Advisory 2010-002: Jiaoli Miraculuous Cream (Jiaoli); Jiaoli Huichusu Special Cut Genuine (Jiaoli Huichusu); and Jiaoli 2+1 7 days Clearing Facial Spots Suit (Jiaoli) Cosmetic Products
Paunawa Mula sa DOH - FDA Blg. 2010-001: Babala sa publiko tungkol sa Food Supplements
FDA CIRCULAR 2010-002: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
FDA CIRCULAR 2010-001: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
DOH-FDA Advisory 2009-010:Reported Proliferation of Expired Processed Food Products Including Dairy Products in the Market
BFAD CITIZEN'S CHARTER (RA 9485 - Anti-Red Tape)
CPSC Urges Parents to Inspect and Secure TVs, Furniture, and Appliances in Child-Proofing Efforts
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10351.html
On average, one child dies every two weeks due to tipovers
NEWS from CPSC
U.S. Consumer Product Safety Commission
Office of Information and Public Affairs Washington, DC 20207
FOR IMMEDIATE RELEASE
September 23, 2010
Release #10-351 CPSC Recall Hotline: (800) 638-2772
CPSC Media Contact: (301) 504-7908
CPSC Urges Parents to Inspect and Secure TVs, Furniture, and Appliances in Child-Proofing Efforts
On average, one child dies every two weeks due to tipovers
WASHINGTON, D.C. - Many parents and caregivers may not be aware that one of the top hidden hazards in the homes where young children live or visit is unsecured and
unstable TVs, furniture and appliances. Today, the U.S. Consumer Product Safety Commission (CPSC) is urging families to take a moment to inspect and secure these
items to prevent any more tragedies.
Between 2000 and 2008, CPSC staff received reports of nearly 200 tipover related deaths involving children eight years old and younger. Nearly all of these fatalities (93%) involved children five years old and younger.
More than 16,000 children five years old and younger were treated in emergency rooms because of injuries associated with TVs, furniture, and appliance tipovers according to CPSC staff’s most recent estimates from 2006.
“Large TVs and unstable furniture can be a deadly combination. Taking simple, low-cost steps to secure furniture and TVs can save lives,” said CPSC Chairman Inez
Tenenbaum. “Parents need to know about this hidden danger and take action now.”
Typically, injuries and deaths occur when children climb onto, fall against or pull themselves up on television stands, shelves, bookcases, dressers, desks, chests and appliances. In some cases, televisions placed on top of furniture will tip over and cause a child to suffer traumatic and sometimes fatal injuries.
To help prevent tip-over hazards, the CPSC offers the following safety tips:
* Furniture should be stable on its own. For added security, anchor chests, dressers, TV stands, bookcases and entertainment units to the floor or attach them to a wall.
* Place TVs on a sturdy, low-rise base. Avoid flimsy shelves.
* Push the TV as far back on its stand as possible.
* Place electrical cords out of a child’s reach and teach kids not to play with them.
* Keep remote controls and other attractive items off the TV stand so kids won’t be tempted to grab for them and risk knocking the TV over.
* Make sure free-standing ranges and stoves are installed with anti-tip brackets.
This year, the CPSC is intensifying its outreach efforts by partnering with numerous organizations, including clinics and second-hand stores, to disseminate a two minute PSA (transcript) including a powerful testimonial of a parent who lost her two-year-old in a TV tipover incident and a poster (pdf). In addition, consumers will be able to stream a 20 second version (transcript) of the PSA through October 23, 2010 by texting TVFALL to 878787.
Consumers can also download CPSC's updated safety alert (pdf).
DOH GEARS UP FOR LOCAL BREASTFEEDING CAMPAIGN
http://www.doh.gov.ph/
Health Secretary Enrique T. Ona reminds the public about the importance of breastfeeding within the first hour of life and called on health facilities providing healthcare for pregnant women, new mothers and newborns to follow the Ten Steps To Successful Breastfeeding.
During the ‘Breastfeeding Awareness Week’ held at the St. Luke’s Medical Center, Health Assistant Secretary Elmer Punzalan commended the participation of the SLMC as among the first private health facilities to respond to the DOH’s call to implement the Ten Steps To Successful Breastfeeding.
Health Secretary Enrique T. Ona reminds the public about the importance of breastfeeding within the first hour of life and called on health facilities providing healthcare for pregnant women, new mothers and newborns to follow the Ten Steps To Successful Breastfeeding.
During the ‘Breastfeeding Awareness Week’ held at the St. Luke’s Medical Center, Health Assistant Secretary Elmer Punzalan commended the participation of the SLMC as among the first private health facilities to respond to the DOH’s call to implement the Ten Steps To Successful Breastfeeding.
Globally, the Philippines is one of 33 countries that have completed the World Breastfeeding Trends Initiative. There are some 40 countries undergoing training towards completing the World Breastfeeding Trends Initiative.
Presently, about 28% of all maternity facilities in the world have implemented the Ten Steps to Successful Breastfeeding. This has contributed to an encouraging increase in breastfeeding rates despite aggressive commercial promotion of infant formula and baby bottles.
The Ten Steps To Successful Breastfeeding are as follows: 1) Have a written breastfeeding policy that is communicated routinely to all healthcare staff; 2) Train all health-care staff in the skills necessary to implement the policy; 3) Inform all pregnant women about the benefits and management of breastfeeding; 4) Help mothers initiate breastfeeding within the first 30 minutes of life; 5) Show mothers how to breastfeed and how to maintain lactation even if separated from their infants; 6) Give newborn infants no food or drink other than human milk unless medically-indicated; 7) Practice rooming- in. Allow mothers and infants to stay together 24 hours a day; 8) Encourage breastfeeding on demand; 9) Give no artificial teats or pacifiers; and 10) Foster establishment of breastfeeding support groups and refer mothers on discharge from hospital or clinic.
FDA approves first oral drug to reduce MS relapses
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm226755.htm
FDA significantly restricts access to the diabetes drug Avandia
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm226975.htm
Learn How You Can Prevent and Control Rabies. Everyday.
http://www.cdc.gov/Features/Rabies/
U.S FDA New and Generic Drug Approvals September 22, 2010
September 22, 2010
* Alprazolam Tablets, Boca Pharmacal, Inc., Approval
* Asmanex Twisthaler (mometasone furoate) Inhalation Powder, Schering-Plough Corporation, Approval
* Atomoxetine Hydrochloride Capsules, Zydus Pharmaceuticals, Approval
* Atazanavir Sulfate Capsules, Matrix Laboratories Ltd., Tentative Approval
* Casodex (bicalutamide) Tablets, AstraZeneca Pharmaceuticals, Labeling Revision
* Duloxetine Hydrochloride Delayed-Release Capsules, Zydus Pharmaceuticals, Tentative Approval
* Fosinopril Sodium and Hydrochlorothiazide Tablets, Actavis Totowa LLC, Approval
* Gemfibrozil Tablets, Northstar Healthcare Holdings Ltd., Approval
* Nifedipine Extended-Release Tablets, Matrix Laboratories Ltd., Approval
* Nizoral A-D (ketoconazole) Shampoo, McNeil Consumer Healthcare, Approval
* Rifampin Injection, Covenant Pharma, Inc., Approval
* Tacrolimus Capsules, Mylan Pharmaceuticals, Inc., Approval
FDA's MedWatch Safety Alerts: August 2010
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm226967.htm
Risky Sexual Enhancers
Prolatis, Novacare LLC Products, Mr. Magic Male Enhancer, TimeOut Capsules and Revivexxx Extra Strength, marketed as dietary supplements for sexual enhancement, contain undeclared ingredients. Novacare LLC Products are sold under the names of Stiff Nights, Aziffa, Size Matters, Erex, Mojo, Hard Drive, Eyeful, Red Magic, Straight Up, Zotrex, Monster Excyte, WOW, Xaitrex, Verect, Prolatis, Xytamax, Maxyte, Libidinal, OMG, OMG45, and Zilex (with Golden Spear)
The undeclared chemicals in these products may lower blood pressure to dangerous levels if taken with nitrate-containing prescription drugs, such as those used to treat diabetes, high cholesterol, and other conditions.
Recommendations
* Stop using these products immediately.
* If you have experienced any bad side effects while using these products, report them to your health professional.
For More Information
* Prolatis: Undeclared Drug Ingredient4
* Novacare LLC Products:Recall -- Undeclared Drug Ingredient5
* Mr. Magic Drug Enhancer: Undeclared Drug Ingredient6
* TimeOut Capsules: Undeclared Drug Ingredient7
Dangerous Weight Control Pills
Solo Slim and Solo Slim Extra Strength products contain an undeclared ingredient to reduce appetite that should be used only in drugs prescribed by a doctor. The ingredient may present a significant health risk for patients with a history of various heart diseases.
Recommendations
* Stop using these products immediately, and return them to the store for a refund.
* If you have experienced any bad side effects while using these products, report them to your health professional.
For More Information
* Solo Slim, Solo Slim Extra Strength: Recall - Undeclared Drug Ingredient8
Poorly Performing Tourniquets
Suspected counterfeit Combat Application Tourniquets (C-A-T®) have a weak tension rod that breaks or bends before the strap can be sufficiently tightened to stop the blood flow.
The resulting excessive blood loss can endanger the victim’s life and ultimately lead to death.
Recommendations
* Use only C-A-T® tourniquets manufactured by Composite Resources and purchased from an authorized distributor.
* If you have C-A-T® tourniquets you suspect may be counterfeit, replace them with the genuine devices.
* If you suspect your tourniquet is counterfeit, contact the FDA’s Office of Criminal Investigations (OCI): Alex Alvarado, special agent, FDA Office of Criminal Investigations – (240) 276-9407.
For More Information
* Combat Application Tourniquets (CAT): Suspected Counterfeit Product9
* FDA's Office of Criminal Investigations10
Infected Blood-Testing Devices
There has been an increase in blood infections (mostly of hepatitis B) transmitted by reusable fingersticks and other skin-puncturing devices such as blood glucose meters, anticoagulation meters, and cholesterol testing devices that are used to draw small blood specimens for testing. When used on more than one patient, these devices may not be safe because it is difficult to clean and disinfect them enough to remove all of the blood.
Recommendation
* Blood-lancing devices should be used only by one patient and should not be shared.
* If that's not feasible, the devices should be thoroughly cleaned and disinfected as described in the labeling.
For More Information
* Fingerstick Devices To Obtain Blood Specimens -- Initial Communication -- Risk of Transmitting Blood Pathogens
Page Last Updated: 09/24/2010
Siemens Recalls Circuit Breakers Due to Fire Hazard
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10354.html
Taking Care of Myself: A Guide for When I Leave the Hospital
http://www.ahrq.gov/qual/goinghomeguide.htm
Taking Care of Myself: A Guide for When I Leave the Hospital is a guide for patients to help them care for themselves when they leave the hospital. The easy-to-read guide can be used by both hospital staff and patients during the discharge process and provides a way for patients to track their medication schedules, upcoming medical appointments, and important phone numbers.
Download the print version and fill-able PDF (PDF File, 775 KB; PDF Help) to your computer and complete all of the information.
This guide is also available in Spanish.
Contents
Using the Guide
Taking Care of Myself: A Guide for When I Leave the Hospital
About the Guide
Using the Guide
Taking Care of Myself: A Guide for When I Leave the Hospital is a guide that providers can use to give patients the information they need to help them care for themselves when they leave the hospital.
How to use the fill-able PDF file:
Using Adobe® Acrobat® (which allows you to view, create, and save PDF files):
1. Open the file and type your information in the spaces provided.
2. Save the file to your computer.
3. Print the file, if desired.
Using Acrobat Reader® (which allows you to view PDF files):
1. Open the file and type your information in the spaces provided.
2. Print the file.
Note: You will not be able to save any changes made to the PDF file.
Hospital staff use:
* Download the fill-able PDF to your computer and complete all of the information in the guide (except patient question sections).
* Talk with patients about the information in the guide.
* Confirm that patients understand instructions by asking patients to describe, in their own words, what they will do when they leave the hospital (e.g., when and how they will take their medicine, when they will go to their doctor's office).
* Give the patient a copy of the completed guide to take home and instruct them to take it to future medical appointments.
Patient use:
* Become familiar with the information covered in the guide before you enter the hospital.
* Make sure that the information about you in the guide is correct (e.g. medication allergies, contact information, primary care provider information).
* Study the guide with your clinicians to make sure you or your family members understand everything that is in it and how to care for yourself when you get home.
* Take the guide to your future medical appointments.
How to Order A Copy of This Guide
To get a free copy of this guide, send an E-mail to the AHRQ Publications Clearinghouse at AHRQPubs@ahrq.hhs.gov or call 1-800-358-9295 and ask for AHRQ Publication No. 10-0059. For other consumer and patient materials, go to the AHRQ Web site at: http://www.ahrq.gov/consumer.
Taking Care of Myself: A Guide for When I Leave the Hospital
To use this guide you should:
* Talk with the hospital staff about each of the items that are listed in the guide.
* Take the completed guide home with you. It will help you to take care of yourself when you go home.
* Share the guide with your family members and others who want to help you. The guide will help them know how to help take care of you.
* Bring the guide to all of your doctor appointments so the doctor knows what you have been doing to care for yourself since you left the hospital.
When you leave the hospital, there are a lot of things you need to do to take care of yourself. You need to see your doctor, take your medicines, exercise, eat healthy foods, and know whom to call with questions or problems. This guide helps you keep track of all the things you need to do.
My name: _______________________________________________
When I'm leaving the hospital _______________________________
If I have questions or problems, I should call:
________________________________________________________
Phone number: __________________________________________
If I have a serious health problem, I should call:
________________________________________________________
Phone number: ___________________________________________
Bring this plan to all your medical appointments.
What is my medical problem?
______________________________________________________________________________
______________________________________________________________________________
What are my medication allergies?
______________________________________________________________________________
______________________________________________________________________________
Where is my pharmacy?
______________________________________________________________________________
______________________________________________________________________________
What exercises are good for me?
______________________________________________________________________________
______________________________________________________________________________
What should I eat?
______________________________________________________________________________
______________________________________________________________________________
What activities or foods should I avoid?
______________________________________________________________________________
______________________________________________________________________________
What medicines do I need to take?
Each day, follow this schedule:
Morning Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much
do I take? How do I take this medicine?
Afternoon Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much do I take? How do I take this medicine?
Evening Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much do I take? How do I take this medicine?
Bedtime Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much do I take? How do I take this medicine?
What other medicines can I take?
Medication name
and amount How much
do I take? How do I take this medicine?
If I need medicine for a headache
If I need medicine to stop smoking
If I need medicine for
______________
If I need medicine for
_____________
If I need medicine for
_____________
If I need medicine for
_____________
If I need medicine for
_____________
If I need medicine for
_____________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
Other questions or concerns ________________________________________
___________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
___ Other questions or concerns ____________________________________
__________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
___ Other questions or concerns ____________________________________
__________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
___ Other questions or concerns ____________________________________
__________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
___ Other questions or concerns ____________________________________
__________________________________________________________
Notes about my medical problem
About the Guide
Taking Care of Myself: A Guide for When I Leave the Hospital is adapted from the Project RED (Re-Engineered Discharge), which was funded by the Agency for Healthcare Research and Quality and the National Heart, Lung, and Blood Institute and operated by the Boston University Medical Center. Project RED showed that preparing patients to care for themselves when they leave the hospital can improve patient safety and reduce re-hospitalization rates. Giving patients an easy-to-understand discharge plan is 1 of 11 elements in the RED process.
More information about Project RED and tools to support some of the other elements of the RED can be obtained at: https://www.bu.edu/fammed/projectred/ Exit Disclaimer
More detailed tools for implementing RED, and revisions of existing tools to ensure that diverse populations—especially patients with limited English proficiency, are now being developed. The tools will be completed by late 2012 and posted on the AHRQ Web site and the Boston University Medical Center's Project RED Web site.
AHRQ Publication Number 10-0059-C
Current as of April 2010
Internet Citation:
Taking Care of Myself: A Guide for When I Leave the Hospital. AHRQ Publication No. 10-0059-C, April 2010. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/goinghomeguide.htm
AHRQ
____________________________________________________________________________________________________________________________________________________________
Lax security on September 24, 2010, at entrance to SM Building at Ayala Center, Makati. The guards at said entrance didn't inspect my luggage/didn't
subject said luggage to scanning with metal detector. Said luggage was large enough to contain firearms. After entering said building, I bought
from the Chowking store in said building. I have the official receipt issued by said store. The employee at said store didn't have the required
health certificate at the proper position on the clothing she was wearing. No visible express lane for senior citizens in the customer area of
said store. No sign, etc. in the customer area of said store regarding the privileges of senior citizens. I believe said store violated the
implementing rules and regulations of the Expanded Senior Citizens Act of 2003.
Advisory re Digitel Mobile Philippines Inc. Level 1, Space No. 233, Robinsons Place, P. Faura St., Ermita, Manila. On Sept. 23, 2010, said corporation
sold to me a USB Modem, which was stated as compatible with Windows 7 operating system. However, when I tried to use said Modem using Windows 7
operating system to access the Internet, I was unsuccessful. Proof of purchase is said corporation's O.R. No. BRE-1-000540443.
_____________________________________________________________________________________
Based on the registry return receipt for my letter, designated as 6_29_10_4, said letter addressed to the Bureau of Food and Drug, was received on 05_07_2010 by the
Food and Drug Administration. Despite R.A. 6713, which said bureau is required to obey, up to September 17, 2010,
said bureau has not provided me with acknowledgment that it received said letter and has not informed me what it did with said letter.
http://www.bfad.gov.ph/cfc/pdf.cfm?pdfid=1473
FDA Circular No. 2010-015
Declaring the Identified Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or
Distribution
FDA approves pediatric use of chemical poisoning treatment
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225347.htm
facts random history web site
http://facts.randomhistory.com/
Nationwide Philhealth Registration Day
Philhealth Sabado - October 2PhilHealth Sabado (October 2, 2010) is the start of a continuing advocacy program to increase awareness and knowledge of every Filipino on the importance of becoming a PhilHealth member that will ensure access to quality health services to the member and his/her dependents.
http://www.doh.gov.ph/node/2804.html
The program intends the registration of non-member informal sector under the individually paying program (IPP). It also provides for an opportunity to automatically register and distribute PhilHealth cards to about 800,000 indigents identified in the National Household Targeting System (NHTS) of the Department of Social Welfare and Development (DSWD).
PhilHealth Sabado fullfill universal health insurance coverage within three years as promised in the first State of the Nation Address of President Benigno S. Aquino III.
1. Paraan ng Pagpaparehistro
2. Paraan ng Paggamit
- Sponsored Program Members
- Individually Paying Members
3. Alamin ang Inyong Benepisyo
4. Frequently Asked Questions
PRESENTATIONS
1. National Philhealth Registration Day
2. National Philhealth Registration Day - Communication Plan
3. Dry-Run of the National Philhealth Registration Day
4. NPRD Joint Agreement
FDA issues new dosing guidance for children using Valcyte
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225887.htm
For Immediate Release: Sept. 15, 2010
Media Inquiries: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
Updated drug label will help prevent potential overdose in underweight transplant patients
The U.S. Food and Drug Administration is notifying health care professionals of updated dosing recommendations for Valcyte (valganciclovir) oral tablets and solution used by children and adolescents receiving a kidney or heart transplant. The update is intended to prevent drug overdosing of children with low body weight, low body surface area, and very low serum creatinine. The revised dosing instructions now appear in the product’s label.
The revised pediatric dosing recommendations now include an upper limit on “calculated creatinine clearance,” a measurement of kidney function. Creatinine is a waste product produced by the body during energy production and is eliminated by the kidneys.
Creatinine levels in the blood are used to estimate how well kidneys are functioning. High creatinine levels may signal poor kidney function, while low creatinine levels may be observed in patients who are not muscular.
Valcyte is an antiviral medication that can be effective for the prevention of cytomegalovirus (CMV) disease in children from 4 months to 16 years of age who have undergone a kidney or heart transplant and who are at a higher risk of getting the disease. CMV is a virus that can cause severe disease such as pneumonia or colitis in people with weakened immune systems, including organ transplant patients.
People using the medication should speak with their health care professional if they have questions about their Valcyte dose.
The medication is also approved to treat CMV retinitis (when the virus infects the eyes) in adults who have acquired immunodeficiency syndrome (AIDS) and is used to prevent CMV disease in people who have received a heart, kidney, or kidney-pancreas transplant with a high risk of getting CMV disease.
Valcyte is manufactured by San Francisco-based Genentech, a member of the Roche Group.
For more information:
Valcyte Drug Safety Communication
http://www.fda.gov/Drugs/DrugSafety/ucm225727.htm
#
RSS Feed for FDA News Releases [what is RSS?]
-
-
Links on this page:
1. http://www.fda.gov/MedWatch/report.htm
2. http://www.fda.gov/MedWatch/getforms.htm
3. http://www.fda.gov/Drugs/DrugSafety/ucm225727.htm
4. http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/PressReleases/rss.xml
5. http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/ucm144575.htm
Page Last Updated: 09/15/2010
http://ocw.mit.edu/index.htm
free online course materials Massachusetts Institute of Technology
The Cost of Flooding
http://www.floodsmart.gov/floodsmart/pages/flooding_flood_risks/the_cost_of_flooding.jsp
All it takes is a few inches of water to cause major damage to your home and its contents. This interactive tool shows you what a flood to your home could cost,
inch by inch.
Manila Health Department refused to accept letter?
I sent a letter to the Manila Health Department. Said letter was designated as registered letter No. 1889. Said letter was mailed on April 25, 2010.
I received back said letter.Based on the marking on the said envelope, said department refused to accept said letter.
Food and Drug Administration Philippines News and Announcements
News and Announcements
DOH_FDA_ADVISORY_2010-010: Product Recall Order For Alactagrow Bibo Trio Milk Supplement Covered by Registration No. FR-71538
DOH_FDA_ADVISORY_2010-009: Product Recall Order of Sustagen Junior Milk Drink Powder Vanilla Flavor (For 1-3 Years Old) Covered by Registration Number FR-72110
FDAC 2010-015: Declaring the Identified Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution
PNS/FDA 27:2010: Recommended Code of Practice for the Processing and Handling of Smoked Fish
PNS/FDA 26:2010: Smoked Fish - Specification
PNS/FDA 25:2010: Recommended Code of Practice for the Processing and Handling of Purple Yam (Ube) Jam (Halaya)
PNS/FDA 24:2010: Purple Yam (Ube) Jam (Halaya) - Specification
PNS/BFAD 29:2010: Recommended Code of Practice for the Processing and Handling of Processed Pili Nut Products
PNS/BFAD 28:2010: Processed Pili Nut Products - Specification
PNS/BFAD 23:2010: Recommended Code of Practice for the Processing and Handling of Fried Corn Snacks (Chichacorn)
PNS/BFAD 22:2010: Fried Corn Snacks (Chichacorn) - Specification
ASEAN Current Good Manufacturing Practice (cGMP) on Cosmetics
Paunawa mula sa DOH-FDA Blg. 2010-007: Babala sa Publiko Tungkol sa mga Produktong Herbal na Walang Label
FDAC 2010-011: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
Transplant Experts Commend DOH Issuance of AO on Deceased Donors Program
DOH Issues Administrative Order on Deceased Organ Donors
Statement of the Food and Drug Administration
DOH Mahalagang Paalala: Ang Food/Dietary Supplements ay HINDI GAMOT...........
FDA Circular No. 2010-009: Amendment to Memorandum Circular No. 05 series of 1994 regarding Reports on Adversed Drug Reaction
FDA Circular No. 2010-008: Adoption of the CODEX Standards of Food Contaminants in Processed Foods
DOH-FDA Advisory 2010-006: Reported Recall of Certain Infant and Children and Over-the-Counter Products Manufactured in the United States
FDA Advisory No. 2010-005: Rotarix Vaccine
FDA Advisory No. 2010-004: FDA Findings on Wheat Flour Imported from Turkey
AO 2010-0008: Directive Specific to the Change in the Use of the Phrase "No Approved Therapeutic Claim" in all Advertisement, Promotional, and/or Sponsorship Activities or Materials concerning Food/Dietary Supplements.
FDA Circular No. 2010-004: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
FDA Advisory 2010-003: Zhen De Shou Fat Loss Capsule and Zhen De Shou Fat Loss Tea
FDA Advisory 2010-002: Jiaoli Miraculuous Cream (Jiaoli); Jiaoli Huichusu Special Cut Genuine (Jiaoli Huichusu); and Jiaoli 2+1 7 days Clearing Facial Spots Suit (Jiaoli) Cosmetic Products
Paunawa Mula sa DOH - FDA Blg. 2010-001: Babala sa publiko tungkol sa Food Supplements
FDA CIRCULAR 2010-002: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
FDA CIRCULAR 2010-001: Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution.
DOH-FDA Advisory 2009-010:Reported Proliferation of Expired Processed Food Products Including Dairy Products in the Market
BFAD CITIZEN'S CHARTER (RA 9485 - Anti-Red Tape)
CPSC Urges Parents to Inspect and Secure TVs, Furniture, and Appliances in Child-Proofing Efforts
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10351.html
On average, one child dies every two weeks due to tipovers
NEWS from CPSC
U.S. Consumer Product Safety Commission
Office of Information and Public Affairs Washington, DC 20207
FOR IMMEDIATE RELEASE
September 23, 2010
Release #10-351 CPSC Recall Hotline: (800) 638-2772
CPSC Media Contact: (301) 504-7908
CPSC Urges Parents to Inspect and Secure TVs, Furniture, and Appliances in Child-Proofing Efforts
On average, one child dies every two weeks due to tipovers
WASHINGTON, D.C. - Many parents and caregivers may not be aware that one of the top hidden hazards in the homes where young children live or visit is unsecured and
unstable TVs, furniture and appliances. Today, the U.S. Consumer Product Safety Commission (CPSC) is urging families to take a moment to inspect and secure these
items to prevent any more tragedies.
Between 2000 and 2008, CPSC staff received reports of nearly 200 tipover related deaths involving children eight years old and younger. Nearly all of these fatalities (93%) involved children five years old and younger.
More than 16,000 children five years old and younger were treated in emergency rooms because of injuries associated with TVs, furniture, and appliance tipovers according to CPSC staff’s most recent estimates from 2006.
“Large TVs and unstable furniture can be a deadly combination. Taking simple, low-cost steps to secure furniture and TVs can save lives,” said CPSC Chairman Inez
Tenenbaum. “Parents need to know about this hidden danger and take action now.”
Typically, injuries and deaths occur when children climb onto, fall against or pull themselves up on television stands, shelves, bookcases, dressers, desks, chests and appliances. In some cases, televisions placed on top of furniture will tip over and cause a child to suffer traumatic and sometimes fatal injuries.
To help prevent tip-over hazards, the CPSC offers the following safety tips:
* Furniture should be stable on its own. For added security, anchor chests, dressers, TV stands, bookcases and entertainment units to the floor or attach them to a wall.
* Place TVs on a sturdy, low-rise base. Avoid flimsy shelves.
* Push the TV as far back on its stand as possible.
* Place electrical cords out of a child’s reach and teach kids not to play with them.
* Keep remote controls and other attractive items off the TV stand so kids won’t be tempted to grab for them and risk knocking the TV over.
* Make sure free-standing ranges and stoves are installed with anti-tip brackets.
This year, the CPSC is intensifying its outreach efforts by partnering with numerous organizations, including clinics and second-hand stores, to disseminate a two minute PSA (transcript) including a powerful testimonial of a parent who lost her two-year-old in a TV tipover incident and a poster (pdf). In addition, consumers will be able to stream a 20 second version (transcript) of the PSA through October 23, 2010 by texting TVFALL to 878787.
Consumers can also download CPSC's updated safety alert (pdf).
DOH GEARS UP FOR LOCAL BREASTFEEDING CAMPAIGN
http://www.doh.gov.ph/
Health Secretary Enrique T. Ona reminds the public about the importance of breastfeeding within the first hour of life and called on health facilities providing healthcare for pregnant women, new mothers and newborns to follow the Ten Steps To Successful Breastfeeding.
During the ‘Breastfeeding Awareness Week’ held at the St. Luke’s Medical Center, Health Assistant Secretary Elmer Punzalan commended the participation of the SLMC as among the first private health facilities to respond to the DOH’s call to implement the Ten Steps To Successful Breastfeeding.
Health Secretary Enrique T. Ona reminds the public about the importance of breastfeeding within the first hour of life and called on health facilities providing healthcare for pregnant women, new mothers and newborns to follow the Ten Steps To Successful Breastfeeding.
During the ‘Breastfeeding Awareness Week’ held at the St. Luke’s Medical Center, Health Assistant Secretary Elmer Punzalan commended the participation of the SLMC as among the first private health facilities to respond to the DOH’s call to implement the Ten Steps To Successful Breastfeeding.
Globally, the Philippines is one of 33 countries that have completed the World Breastfeeding Trends Initiative. There are some 40 countries undergoing training towards completing the World Breastfeeding Trends Initiative.
Presently, about 28% of all maternity facilities in the world have implemented the Ten Steps to Successful Breastfeeding. This has contributed to an encouraging increase in breastfeeding rates despite aggressive commercial promotion of infant formula and baby bottles.
The Ten Steps To Successful Breastfeeding are as follows: 1) Have a written breastfeeding policy that is communicated routinely to all healthcare staff; 2) Train all health-care staff in the skills necessary to implement the policy; 3) Inform all pregnant women about the benefits and management of breastfeeding; 4) Help mothers initiate breastfeeding within the first 30 minutes of life; 5) Show mothers how to breastfeed and how to maintain lactation even if separated from their infants; 6) Give newborn infants no food or drink other than human milk unless medically-indicated; 7) Practice rooming- in. Allow mothers and infants to stay together 24 hours a day; 8) Encourage breastfeeding on demand; 9) Give no artificial teats or pacifiers; and 10) Foster establishment of breastfeeding support groups and refer mothers on discharge from hospital or clinic.
FDA approves first oral drug to reduce MS relapses
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm226755.htm
FDA significantly restricts access to the diabetes drug Avandia
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm226975.htm
Learn How You Can Prevent and Control Rabies. Everyday.
http://www.cdc.gov/Features/Rabies/
U.S FDA New and Generic Drug Approvals September 22, 2010
September 22, 2010
* Alprazolam Tablets, Boca Pharmacal, Inc., Approval
* Asmanex Twisthaler (mometasone furoate) Inhalation Powder, Schering-Plough Corporation, Approval
* Atomoxetine Hydrochloride Capsules, Zydus Pharmaceuticals, Approval
* Atazanavir Sulfate Capsules, Matrix Laboratories Ltd., Tentative Approval
* Casodex (bicalutamide) Tablets, AstraZeneca Pharmaceuticals, Labeling Revision
* Duloxetine Hydrochloride Delayed-Release Capsules, Zydus Pharmaceuticals, Tentative Approval
* Fosinopril Sodium and Hydrochlorothiazide Tablets, Actavis Totowa LLC, Approval
* Gemfibrozil Tablets, Northstar Healthcare Holdings Ltd., Approval
* Nifedipine Extended-Release Tablets, Matrix Laboratories Ltd., Approval
* Nizoral A-D (ketoconazole) Shampoo, McNeil Consumer Healthcare, Approval
* Rifampin Injection, Covenant Pharma, Inc., Approval
* Tacrolimus Capsules, Mylan Pharmaceuticals, Inc., Approval
FDA's MedWatch Safety Alerts: August 2010
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm226967.htm
Risky Sexual Enhancers
Prolatis, Novacare LLC Products, Mr. Magic Male Enhancer, TimeOut Capsules and Revivexxx Extra Strength, marketed as dietary supplements for sexual enhancement, contain undeclared ingredients. Novacare LLC Products are sold under the names of Stiff Nights, Aziffa, Size Matters, Erex, Mojo, Hard Drive, Eyeful, Red Magic, Straight Up, Zotrex, Monster Excyte, WOW, Xaitrex, Verect, Prolatis, Xytamax, Maxyte, Libidinal, OMG, OMG45, and Zilex (with Golden Spear)
The undeclared chemicals in these products may lower blood pressure to dangerous levels if taken with nitrate-containing prescription drugs, such as those used to treat diabetes, high cholesterol, and other conditions.
Recommendations
* Stop using these products immediately.
* If you have experienced any bad side effects while using these products, report them to your health professional.
For More Information
* Prolatis: Undeclared Drug Ingredient4
* Novacare LLC Products:Recall -- Undeclared Drug Ingredient5
* Mr. Magic Drug Enhancer: Undeclared Drug Ingredient6
* TimeOut Capsules: Undeclared Drug Ingredient7
Dangerous Weight Control Pills
Solo Slim and Solo Slim Extra Strength products contain an undeclared ingredient to reduce appetite that should be used only in drugs prescribed by a doctor. The ingredient may present a significant health risk for patients with a history of various heart diseases.
Recommendations
* Stop using these products immediately, and return them to the store for a refund.
* If you have experienced any bad side effects while using these products, report them to your health professional.
For More Information
* Solo Slim, Solo Slim Extra Strength: Recall - Undeclared Drug Ingredient8
Poorly Performing Tourniquets
Suspected counterfeit Combat Application Tourniquets (C-A-T®) have a weak tension rod that breaks or bends before the strap can be sufficiently tightened to stop the blood flow.
The resulting excessive blood loss can endanger the victim’s life and ultimately lead to death.
Recommendations
* Use only C-A-T® tourniquets manufactured by Composite Resources and purchased from an authorized distributor.
* If you have C-A-T® tourniquets you suspect may be counterfeit, replace them with the genuine devices.
* If you suspect your tourniquet is counterfeit, contact the FDA’s Office of Criminal Investigations (OCI): Alex Alvarado, special agent, FDA Office of Criminal Investigations – (240) 276-9407.
For More Information
* Combat Application Tourniquets (CAT): Suspected Counterfeit Product9
* FDA's Office of Criminal Investigations10
Infected Blood-Testing Devices
There has been an increase in blood infections (mostly of hepatitis B) transmitted by reusable fingersticks and other skin-puncturing devices such as blood glucose meters, anticoagulation meters, and cholesterol testing devices that are used to draw small blood specimens for testing. When used on more than one patient, these devices may not be safe because it is difficult to clean and disinfect them enough to remove all of the blood.
Recommendation
* Blood-lancing devices should be used only by one patient and should not be shared.
* If that's not feasible, the devices should be thoroughly cleaned and disinfected as described in the labeling.
For More Information
* Fingerstick Devices To Obtain Blood Specimens -- Initial Communication -- Risk of Transmitting Blood Pathogens
Page Last Updated: 09/24/2010
Siemens Recalls Circuit Breakers Due to Fire Hazard
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10354.html
Taking Care of Myself: A Guide for When I Leave the Hospital
http://www.ahrq.gov/qual/goinghomeguide.htm
Taking Care of Myself: A Guide for When I Leave the Hospital is a guide for patients to help them care for themselves when they leave the hospital. The easy-to-read guide can be used by both hospital staff and patients during the discharge process and provides a way for patients to track their medication schedules, upcoming medical appointments, and important phone numbers.
Download the print version and fill-able PDF (PDF File, 775 KB; PDF Help) to your computer and complete all of the information.
This guide is also available in Spanish.
Contents
Using the Guide
Taking Care of Myself: A Guide for When I Leave the Hospital
About the Guide
Using the Guide
Taking Care of Myself: A Guide for When I Leave the Hospital is a guide that providers can use to give patients the information they need to help them care for themselves when they leave the hospital.
How to use the fill-able PDF file:
Using Adobe® Acrobat® (which allows you to view, create, and save PDF files):
1. Open the file and type your information in the spaces provided.
2. Save the file to your computer.
3. Print the file, if desired.
Using Acrobat Reader® (which allows you to view PDF files):
1. Open the file and type your information in the spaces provided.
2. Print the file.
Note: You will not be able to save any changes made to the PDF file.
Hospital staff use:
* Download the fill-able PDF to your computer and complete all of the information in the guide (except patient question sections).
* Talk with patients about the information in the guide.
* Confirm that patients understand instructions by asking patients to describe, in their own words, what they will do when they leave the hospital (e.g., when and how they will take their medicine, when they will go to their doctor's office).
* Give the patient a copy of the completed guide to take home and instruct them to take it to future medical appointments.
Patient use:
* Become familiar with the information covered in the guide before you enter the hospital.
* Make sure that the information about you in the guide is correct (e.g. medication allergies, contact information, primary care provider information).
* Study the guide with your clinicians to make sure you or your family members understand everything that is in it and how to care for yourself when you get home.
* Take the guide to your future medical appointments.
How to Order A Copy of This Guide
To get a free copy of this guide, send an E-mail to the AHRQ Publications Clearinghouse at AHRQPubs@ahrq.hhs.gov or call 1-800-358-9295 and ask for AHRQ Publication No. 10-0059. For other consumer and patient materials, go to the AHRQ Web site at: http://www.ahrq.gov/consumer.
Taking Care of Myself: A Guide for When I Leave the Hospital
To use this guide you should:
* Talk with the hospital staff about each of the items that are listed in the guide.
* Take the completed guide home with you. It will help you to take care of yourself when you go home.
* Share the guide with your family members and others who want to help you. The guide will help them know how to help take care of you.
* Bring the guide to all of your doctor appointments so the doctor knows what you have been doing to care for yourself since you left the hospital.
When you leave the hospital, there are a lot of things you need to do to take care of yourself. You need to see your doctor, take your medicines, exercise, eat healthy foods, and know whom to call with questions or problems. This guide helps you keep track of all the things you need to do.
My name: _______________________________________________
When I'm leaving the hospital _______________________________
If I have questions or problems, I should call:
________________________________________________________
Phone number: __________________________________________
If I have a serious health problem, I should call:
________________________________________________________
Phone number: ___________________________________________
Bring this plan to all your medical appointments.
What is my medical problem?
______________________________________________________________________________
______________________________________________________________________________
What are my medication allergies?
______________________________________________________________________________
______________________________________________________________________________
Where is my pharmacy?
______________________________________________________________________________
______________________________________________________________________________
What exercises are good for me?
______________________________________________________________________________
______________________________________________________________________________
What should I eat?
______________________________________________________________________________
______________________________________________________________________________
What activities or foods should I avoid?
______________________________________________________________________________
______________________________________________________________________________
What medicines do I need to take?
Each day, follow this schedule:
Morning Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much
do I take? How do I take this medicine?
Afternoon Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much do I take? How do I take this medicine?
Evening Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much do I take? How do I take this medicine?
Bedtime Medicines
Medicines name (generic and name brand and amount) Why am I taking this medicine? How much do I take? How do I take this medicine?
What other medicines can I take?
Medication name
and amount How much
do I take? How do I take this medicine?
If I need medicine for a headache
If I need medicine to stop smoking
If I need medicine for
______________
If I need medicine for
_____________
If I need medicine for
_____________
If I need medicine for
_____________
If I need medicine for
_____________
If I need medicine for
_____________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
Other questions or concerns ________________________________________
___________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
___ Other questions or concerns ____________________________________
__________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
___ Other questions or concerns ____________________________________
__________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
___ Other questions or concerns ____________________________________
__________________________________________________________
When are my next appointments?
Day ____________ Date ____________
Time _____________________
Doctor's name ______________ Specialty ____________________
Address _____________________________________________________________
____________________________________________________________________
Reason for appointment ___________________________________________________
Doctor's phone number ____________________________________________
Questions for my appointment
Check any of the boxes below and write notes to remember what to discuss with your doctor.
I have questions about:
___ My medicines ________________________________________________
___ My test results ________________________________________________
___ My pain _____________________________________________________
___ Feeling stressed _____________________________________________
___ Other questions or concerns ____________________________________
__________________________________________________________
Notes about my medical problem
About the Guide
Taking Care of Myself: A Guide for When I Leave the Hospital is adapted from the Project RED (Re-Engineered Discharge), which was funded by the Agency for Healthcare Research and Quality and the National Heart, Lung, and Blood Institute and operated by the Boston University Medical Center. Project RED showed that preparing patients to care for themselves when they leave the hospital can improve patient safety and reduce re-hospitalization rates. Giving patients an easy-to-understand discharge plan is 1 of 11 elements in the RED process.
More information about Project RED and tools to support some of the other elements of the RED can be obtained at: https://www.bu.edu/fammed/projectred/ Exit Disclaimer
More detailed tools for implementing RED, and revisions of existing tools to ensure that diverse populations—especially patients with limited English proficiency, are now being developed. The tools will be completed by late 2012 and posted on the AHRQ Web site and the Boston University Medical Center's Project RED Web site.
AHRQ Publication Number 10-0059-C
Current as of April 2010
Internet Citation:
Taking Care of Myself: A Guide for When I Leave the Hospital. AHRQ Publication No. 10-0059-C, April 2010. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/goinghomeguide.htm
AHRQ
____________________________________________________________________________________________________________________________________________________________
Lax security on September 24, 2010, at entrance to SM Building at Ayala Center, Makati. The guards at said entrance didn't inspect my luggage/didn't
subject said luggage to scanning with metal detector. Said luggage was large enough to contain firearms. After entering said building, I bought
from the Chowking store in said building. I have the official receipt issued by said store. The employee at said store didn't have the required
health certificate at the proper position on the clothing she was wearing. No visible express lane for senior citizens in the customer area of
said store. No sign, etc. in the customer area of said store regarding the privileges of senior citizens. I believe said store violated the
implementing rules and regulations of the Expanded Senior Citizens Act of 2003.
Advisory re Digitel Mobile Philippines Inc. Level 1, Space No. 233, Robinsons Place, P. Faura St., Ermita, Manila. On Sept. 23, 2010, said corporation
sold to me a USB Modem, which was stated as compatible with Windows 7 operating system. However, when I tried to use said Modem using Windows 7
operating system to access the Internet, I was unsuccessful. Proof of purchase is said corporation's O.R. No. BRE-1-000540443.
_____________________________________________________________________________________
Monday, September 6, 2010
LAUNCHES ‘D.E.N.G.U.E.’ STRATEGY
http://www.doh.gov.ph/node/2768.html
Sec Ona speaking during launching of dengue strategyPress Release/1 September 2010
The Department of Health (DOH) today assured that many dengue cases, if mild, can be managed at home and not all cases require hospitalization even as the number of cases nationwide from January to August 21 now rose to 62,503.
This figure is 88.8% higher than last year’s 33,102 for the same period. There were 465 deaths recorded this year. Last year, there were 350 deaths.
“Instead of confining patients in a hospital facility, parents and caregivers can practice the D.E.N.G.U.E. strategy. D.E.N.G.U.E. stands for D - daily monitoring of patient’s status, E - encourage intake of oral fluids like oresol, water, juices, etc, N – note any dengue warning signs like persistent vomiting and bleeding, G – give paracetamol for fever and NOT aspirin, because aspirin induces bleeding, U – use mosquito nets and E – early consultation is advised for any warning signs”, Health Secretary Enrique Ona said.
The new D.E.N.G.U.E. strategy has been devised by the DOH to educate the public on home treatment of mild dengue cases. This is to also help decongest hospitals by giving an assurance that not all dengue cases require hospital confinement but can be managed at home using the said strategy.
Ona also reiterated that the most effective way to prevent and fight dengue is still by practicing the DOH’s 4-S strategy consisting of Search and destroy, Self-protective measures, Seek early treatment and Say no to indiscriminate fogging.
“We are urging all local government units to mobilize barangay dengue brigades in their areas,” Ona explained, adding that a once-a-week community-wide clean up drives against dengue will help a lot in reducing cases. Measures include emptying of all exposed containers and vases, old tires, coconut husks, and plants of stagnant waters. Abandoned lots, houses and establishments should also be included in the search-and-destroy operations because these may have possible mosquito breeding sites.
Ona revealed that most of the cases came from Western Visayas (16.1%), CaLaBarzon (10.9%), Central Mindanao (10.5%), Eastern Visayas (9.2%), National Capital Region (8.9%), Southern Mindanao (8.1%) and Northern Mindanao (7.4%).
Ages of cases ranged from 1 month to 95 years old. Majority (52%) of the cases were male. The most affected age group were the 1-10 years while there were more deaths recorded in the less than one year age group and the 1-10 years age group).
Ona disclosed that outbreaks were detected in Roxas City and Iloilo City in Region VI and Zamboanga City in Region IX.
The health chief explained that a hotspot is defined as clustering of cases with increasing number in the past four weeks. Hotspots were observed in the several barangays in the following areas: Lipa City and San Jose in Batangas (Region 4A); Puerto Princesa City in Palawan (Region 4B); Kalibo, Aklan (Region VI); Tagbilaran City, Bohol (Region VII); Pudtol, Apayao (CAR) and ; Kalookan and Valenzuela in NCR.
On the other hand, clustering of cases occur when there are three or more cases in a barangay in the past four weeks. Clustering of cases was noted in many areas in different Regions of the country.
At the National Capital Region, most of the cases were reported from Quezon City.
“The increase in dengue cases can be attributed to the presence of four different strains of the dengue virus circulating in the country today, plus the fact that the country is experiencing the El Niño phenomenon,” Ona elaborated, adding that continuous rains is also responsible for the upsurge in cases.
To more strongly respond to the increasing number of dengue cases, the DOH has ramped up efforts in its public education and information campaign to schools and barangays since July in coordination with its regional health offices and other concerned government agencies such as the Department of Education (DepEd) and the Department of Interior and Local Government (DILG).
Secretary Ona has also reiterated the directive to activate all dengue express lanes in DOH and to network with regional and provincial blood centers where patients can access safe and clean blood for transfusion in severe cases.
“There is still no cure or vaccine for dengue and that is why we must focus on other cost-effective interventions, the most important of which is source reduction --- destroy the dengue-carrying mosquitoes,” Ona emphasized.
The health department is currently looking into other potential strategies to combat dengue such as the use of vaccines against all four dengue strains, the genetic modification of the Aedes mosquitoes which will render them less active in biting victims and even local alternatives such as the use of “Tawa-tawa”, a local herb that is being investigated for its curative properties against dengue.
“We are on the lookout for the emerging science and trends concerning dengue which can help us to more effectively fight the disease in the future,” says Ona. “Meanwhile, we are doing everything we can to arm the public with information and respond to the medical needs of victims given the tools that are currently available to us,” he added.
Ona reminded the public that dengue, although an all-year round disease, is more common during rainy days when there are more potential breeding grounds for the Aedes aegypti mosquitoes. To prevent dengue, Ona advised the public to destroy all possible mosquito breeding sites like old tires, softdrink bottles and tin cans, and use mosquito nets or protective clothing. He also stressed that fogging may be done only in outbreak areas.
ANTI-DENGUE CAMPAIGN IN LRT
http://www.doh.gov.ph/
Health Secretary Enrique Ona explains to a young boy the Department of Health’s 4-S strategy against dengue Health Secretary Enrique Ona explains to a young boy the Department of Health’s 4-S strategy against dengue because the population most affected by the disease are the 1-10 years age group. The DOH’s 4-S campaign includes Search and destroy all mosquito breeding sites, Seek early consultation once dengue is suspected, wear Self-protective clothing to prevent mosquito bites, and Say no to indiscriminate fogging, because there are certain conditions that should be observed during fogging operation. Assisting Secretary Ona is Light Railway Transit Authority Division Chief Mr. Joseph Hagos. From January to August 21 this year, dengue cases nationwide reached 62,503 with 465 deaths.
Advisory vs. Gigahertz store at SM Megamall in Mandaluyong. On September 1, 2010, an employee at said store accepted an order for creation of a recovery disk for
a computer I was thinking of buying. However, even after I paid for said recovery disk and said computer, said store has not provided me with said disk. Proof
of payment is Gigahertz store sales invoice No. 10830 dated September 1, 2010. In addition, there was no visible required express lane for senior citizens in
the customer area of said store and no visible required sign regarding privileges of senior citizens in the customer area of said store. I believe
said store violated the Expanded Senior Citizens Act of 2003.
Toshiba Recalls T Series Notebook Computers Due to Burn Hazard
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10330.html
U.S. Consumer Product
Safety Commission
www.cpsc.gov Health Canada
www.hc-sc.gc.ca
FOR IMMEDIATE RELEASE
September 2, 2010
Release #10-330 Firm's Recall Hotline: (800) 457-7777
CPSC Recall Hotline: (800) 638-2772
CPSC Media Contact: (301) 504-7908
HC Media Contact: (613) 957-2983
Toshiba Recalls T Series Notebook Computers Due to Burn Hazard
WASHINGTON, D.C. - The U.S. Consumer Product Safety Commission and Health Canada, in cooperation with the firm named below, today announced a voluntary recall of the following consumer product. Consumers should stop using recalled products immediately unless otherwise instructed. It is illegal to resell or attempt to resell a recalled consumer product.
Name of Product: Satellite T135, Satellite T135D and Satellite ProT130 Notebook Computers
Units: About 41,000 worldwide
Manufacturer: Toshiba America Information Systems Inc., of Irvine, Calif.
Hazard: The notebook computers can overheat at the notebook's plug-in to the AC adapter, posing a burn hazard to consumers.
Incidents/Injuries: Toshiba has received 129 reports of the notebook computers overheating and deforming the plastic casing area around the AC adapter plug, including two reports of minor burn injuries that did not require medical attention and two reports of minor property damage.
Description: This recall involves certain Toshiba Satellite T135, Satellite T135D and Satellite Pro T130 notebook computer models. "Toshiba" is printed on the top of the notebook computer. The model name and number are printed on a label on the bottom of the notebook computers.
Sold at: Electronics stores and other retailers nationwide and online, including at Toshibadirect.com and other websites, from August 2009 through August 2010 for between $600 and $800.
Manufactured in: China
Remedy: Consumers should immediately download the latest version of Toshiba's BIOS computer program to their notebook computer at http://laptops.toshiba.com/about/consumer-notices. This new computer program will detect whether the notebook computer is overheating, and if so, disable the notebook computer's external power and display a message directing the consumer to contact Toshiba for a free repair. Consumers who do not have Internet access should contact Toshiba to arrange for installation of the updated BIOS.
Consumer Contact: For additional information, contact Toshiba at (800) 457-7777 anytime or visit the firm's website at http://laptops.toshiba.com/about/consumer-notices
Note: Health Canada's press release is available at http://cpsr-rspc.hc-sc.gc.ca/PR-RP/recall-retrait-eng.jsp?re_id=1157
*
Warning Letters Posted on August 31, 2010
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/default.htm#recent
Letter Issue Date Company Name Issuing Office Subject Close Out Date
August 25, 2010 Specialty Brands of America Center for Food Safety and Applied Nutrition Federal Food, Drug and Cosmetic Act/Misbranded Not Issued *
August 25, 2010 Sun Pharmaceutical Industries Inc New Jersey District Office CGMP for Finished Pharmaceuticals/Adulterated Not Issued *
August 24, 2010 Storz Medical, AG Center for Devices and Radiological Health CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated Not Issued *
August 23, 2010 Sallamander Concepts CC Pty Ltd Center for Devices and Radiological Health Premarket Approval/Misbranded/Adulterated Not Issued *
August 23, 2010 Stericon Pharma Pvt. Ltd. Center for Drug Evaluation and Research CGMP for Finished Pharmaceuticals/Adulterated Not Issued *
August 16, 2010 R&P Seafood Corp. Los Angeles District Office Seafood HACCP/CGMP for Foods/Adulterated Not Issued *
August 09, 2010 Village Green Foods, Inc. Los Angeles District Office Seafood HACCP/CGMP for Foods/Adulterated Not Issued *
August 09, 2010 Diasol Inc Los Angeles District Office CGMP/QSR/Medical Devices/Adulterated Not Issued *
August 05, 2010 BioVeda Florida District Office Premarket Approval/Misbranded/Adulterated Not Issued *
August 03, 2010 Baxter Healthcare Corp Dba Biolife Plasma Center for Biologics Evaluation and Research Misleading Efficacy Claim Not Issued *
June 21, 2010 Alphatec Spine, Inc. Los Angeles District Office CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated/Misbranded Not Issued *
May 12, 2010 Laboratorios L.O., Oftalmi, C.A. Center for Drug Evaluation and Research CGMP for Finished Pharmaceuticals/Adulterated Not Issued *
-
Contact Us
*
Dockets Management
* 301-827-6860
* Fax: 301-827-6870
Division of Dockets Management
Food and Drug Administration
5630 Fishers Lane
Room 1061, HFA-305
Rockville, MD 20852
-
-
-
Links on this page:
1. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2010/default.htm
2. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2009/default.htm
3. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2008/default.htm
4. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2007/default.htm
5. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2006/default.htm
6. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2005/default.htm
7. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2004/default.htm
8. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2003/default.htm
9. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2002/default.htm
10. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2001/default.htm
11. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2000/default.htm
12. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1999/default.htm
13. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1998/default.htm
14. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1997/default.htm
15. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1996/default.htm
16. http://www.fda.govhttps://service.govdelivery.com/service/subscribe.html?code=USFDA_63
17. http://www.accessdata.fda.gov/scripts/warningletters/wlAdvancedSearch.cfm
18. http://www.accessdata.fda.gov/scripts/warningletters/wlFilterByCompany.cfm
19. http://www.accessdata.fda.gov/scripts/warningletters/wlFilterByOffice.cfm
20. http://www.accessdata.fda.gov/scripts/warningletters/wlFilterBySubject.cfm
21. http://www.accessdata.fda.gov/scripts/warningletters/wlSearchResult.cfm?company=&_1_issueDt=&_2_issueDt=&office=&subject=&hasResponseLetter=Yes&hasCloseoutLetter=Both&recsPerPageDef=500&Search=Search&errMsg=
22. http://www.accessdata.fda.gov/scripts/warningletters/wlSearchResult.cfm?company=&_1_issueDt=&_2_issueDt=&office=&subject=&hasResponseLetter=Both&hasCloseoutLetter=Yes&recsPerPageDef=500&Search=Search&errMsg=
23. http://www.accessdata.fda.gov/scripts/warningletters/wlSearchExcel.cfm
24. http://www.fda.gov/RegulatoryInformation/FOI/WhotoContactAboutFOIA/default.htm
25. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224023.htm
26. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224177.htm
27. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224014.htm
28. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224465.htm
29. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223965.htm
30. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223902.htm
31. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223971.htm
32. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223938.htm
33. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223688.htm
34. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224225.htm
35. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223696.htm
36. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223911.htm
Page Last Updated: 06/24/2010
web sites:
http://www.addictivetips.com/
addictivetips com web site
http://www.nasa.gov/multimedia/imagegallery/
nasa gov multimedia image gallery web site
useful free online services:
let simon decide
http://www.letsimondecide.com/
http://hunch.com/
http://www.measy.com/
CDC Hurricane Health & Safety Tip
...
From:
CDC
Tip of the Week: As you prepare for Hurricane, remember to take rubber boots, rubber gloves and goggles with you when you evacuate. They will protect you from
contaminated flood waters when you return after the storm.
http://www.doh.gov.ph/node/2768.html
Sec Ona speaking during launching of dengue strategyPress Release/1 September 2010
The Department of Health (DOH) today assured that many dengue cases, if mild, can be managed at home and not all cases require hospitalization even as the number of cases nationwide from January to August 21 now rose to 62,503.
This figure is 88.8% higher than last year’s 33,102 for the same period. There were 465 deaths recorded this year. Last year, there were 350 deaths.
“Instead of confining patients in a hospital facility, parents and caregivers can practice the D.E.N.G.U.E. strategy. D.E.N.G.U.E. stands for D - daily monitoring of patient’s status, E - encourage intake of oral fluids like oresol, water, juices, etc, N – note any dengue warning signs like persistent vomiting and bleeding, G – give paracetamol for fever and NOT aspirin, because aspirin induces bleeding, U – use mosquito nets and E – early consultation is advised for any warning signs”, Health Secretary Enrique Ona said.
The new D.E.N.G.U.E. strategy has been devised by the DOH to educate the public on home treatment of mild dengue cases. This is to also help decongest hospitals by giving an assurance that not all dengue cases require hospital confinement but can be managed at home using the said strategy.
Ona also reiterated that the most effective way to prevent and fight dengue is still by practicing the DOH’s 4-S strategy consisting of Search and destroy, Self-protective measures, Seek early treatment and Say no to indiscriminate fogging.
“We are urging all local government units to mobilize barangay dengue brigades in their areas,” Ona explained, adding that a once-a-week community-wide clean up drives against dengue will help a lot in reducing cases. Measures include emptying of all exposed containers and vases, old tires, coconut husks, and plants of stagnant waters. Abandoned lots, houses and establishments should also be included in the search-and-destroy operations because these may have possible mosquito breeding sites.
Ona revealed that most of the cases came from Western Visayas (16.1%), CaLaBarzon (10.9%), Central Mindanao (10.5%), Eastern Visayas (9.2%), National Capital Region (8.9%), Southern Mindanao (8.1%) and Northern Mindanao (7.4%).
Ages of cases ranged from 1 month to 95 years old. Majority (52%) of the cases were male. The most affected age group were the 1-10 years while there were more deaths recorded in the less than one year age group and the 1-10 years age group).
Ona disclosed that outbreaks were detected in Roxas City and Iloilo City in Region VI and Zamboanga City in Region IX.
The health chief explained that a hotspot is defined as clustering of cases with increasing number in the past four weeks. Hotspots were observed in the several barangays in the following areas: Lipa City and San Jose in Batangas (Region 4A); Puerto Princesa City in Palawan (Region 4B); Kalibo, Aklan (Region VI); Tagbilaran City, Bohol (Region VII); Pudtol, Apayao (CAR) and ; Kalookan and Valenzuela in NCR.
On the other hand, clustering of cases occur when there are three or more cases in a barangay in the past four weeks. Clustering of cases was noted in many areas in different Regions of the country.
At the National Capital Region, most of the cases were reported from Quezon City.
“The increase in dengue cases can be attributed to the presence of four different strains of the dengue virus circulating in the country today, plus the fact that the country is experiencing the El Niño phenomenon,” Ona elaborated, adding that continuous rains is also responsible for the upsurge in cases.
To more strongly respond to the increasing number of dengue cases, the DOH has ramped up efforts in its public education and information campaign to schools and barangays since July in coordination with its regional health offices and other concerned government agencies such as the Department of Education (DepEd) and the Department of Interior and Local Government (DILG).
Secretary Ona has also reiterated the directive to activate all dengue express lanes in DOH and to network with regional and provincial blood centers where patients can access safe and clean blood for transfusion in severe cases.
“There is still no cure or vaccine for dengue and that is why we must focus on other cost-effective interventions, the most important of which is source reduction --- destroy the dengue-carrying mosquitoes,” Ona emphasized.
The health department is currently looking into other potential strategies to combat dengue such as the use of vaccines against all four dengue strains, the genetic modification of the Aedes mosquitoes which will render them less active in biting victims and even local alternatives such as the use of “Tawa-tawa”, a local herb that is being investigated for its curative properties against dengue.
“We are on the lookout for the emerging science and trends concerning dengue which can help us to more effectively fight the disease in the future,” says Ona. “Meanwhile, we are doing everything we can to arm the public with information and respond to the medical needs of victims given the tools that are currently available to us,” he added.
Ona reminded the public that dengue, although an all-year round disease, is more common during rainy days when there are more potential breeding grounds for the Aedes aegypti mosquitoes. To prevent dengue, Ona advised the public to destroy all possible mosquito breeding sites like old tires, softdrink bottles and tin cans, and use mosquito nets or protective clothing. He also stressed that fogging may be done only in outbreak areas.
ANTI-DENGUE CAMPAIGN IN LRT
http://www.doh.gov.ph/
Health Secretary Enrique Ona explains to a young boy the Department of Health’s 4-S strategy against dengue Health Secretary Enrique Ona explains to a young boy the Department of Health’s 4-S strategy against dengue because the population most affected by the disease are the 1-10 years age group. The DOH’s 4-S campaign includes Search and destroy all mosquito breeding sites, Seek early consultation once dengue is suspected, wear Self-protective clothing to prevent mosquito bites, and Say no to indiscriminate fogging, because there are certain conditions that should be observed during fogging operation. Assisting Secretary Ona is Light Railway Transit Authority Division Chief Mr. Joseph Hagos. From January to August 21 this year, dengue cases nationwide reached 62,503 with 465 deaths.
Advisory vs. Gigahertz store at SM Megamall in Mandaluyong. On September 1, 2010, an employee at said store accepted an order for creation of a recovery disk for
a computer I was thinking of buying. However, even after I paid for said recovery disk and said computer, said store has not provided me with said disk. Proof
of payment is Gigahertz store sales invoice No. 10830 dated September 1, 2010. In addition, there was no visible required express lane for senior citizens in
the customer area of said store and no visible required sign regarding privileges of senior citizens in the customer area of said store. I believe
said store violated the Expanded Senior Citizens Act of 2003.
Toshiba Recalls T Series Notebook Computers Due to Burn Hazard
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10330.html
U.S. Consumer Product
Safety Commission
www.cpsc.gov Health Canada
www.hc-sc.gc.ca
FOR IMMEDIATE RELEASE
September 2, 2010
Release #10-330 Firm's Recall Hotline: (800) 457-7777
CPSC Recall Hotline: (800) 638-2772
CPSC Media Contact: (301) 504-7908
HC Media Contact: (613) 957-2983
Toshiba Recalls T Series Notebook Computers Due to Burn Hazard
WASHINGTON, D.C. - The U.S. Consumer Product Safety Commission and Health Canada, in cooperation with the firm named below, today announced a voluntary recall of the following consumer product. Consumers should stop using recalled products immediately unless otherwise instructed. It is illegal to resell or attempt to resell a recalled consumer product.
Name of Product: Satellite T135, Satellite T135D and Satellite ProT130 Notebook Computers
Units: About 41,000 worldwide
Manufacturer: Toshiba America Information Systems Inc., of Irvine, Calif.
Hazard: The notebook computers can overheat at the notebook's plug-in to the AC adapter, posing a burn hazard to consumers.
Incidents/Injuries: Toshiba has received 129 reports of the notebook computers overheating and deforming the plastic casing area around the AC adapter plug, including two reports of minor burn injuries that did not require medical attention and two reports of minor property damage.
Description: This recall involves certain Toshiba Satellite T135, Satellite T135D and Satellite Pro T130 notebook computer models. "Toshiba" is printed on the top of the notebook computer. The model name and number are printed on a label on the bottom of the notebook computers.
Sold at: Electronics stores and other retailers nationwide and online, including at Toshibadirect.com and other websites, from August 2009 through August 2010 for between $600 and $800.
Manufactured in: China
Remedy: Consumers should immediately download the latest version of Toshiba's BIOS computer program to their notebook computer at http://laptops.toshiba.com/about/consumer-notices. This new computer program will detect whether the notebook computer is overheating, and if so, disable the notebook computer's external power and display a message directing the consumer to contact Toshiba for a free repair. Consumers who do not have Internet access should contact Toshiba to arrange for installation of the updated BIOS.
Consumer Contact: For additional information, contact Toshiba at (800) 457-7777 anytime or visit the firm's website at http://laptops.toshiba.com/about/consumer-notices
Note: Health Canada's press release is available at http://cpsr-rspc.hc-sc.gc.ca/PR-RP/recall-retrait-eng.jsp?re_id=1157
*
Warning Letters Posted on August 31, 2010
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/default.htm#recent
Letter Issue Date Company Name Issuing Office Subject Close Out Date
August 25, 2010 Specialty Brands of America Center for Food Safety and Applied Nutrition Federal Food, Drug and Cosmetic Act/Misbranded Not Issued *
August 25, 2010 Sun Pharmaceutical Industries Inc New Jersey District Office CGMP for Finished Pharmaceuticals/Adulterated Not Issued *
August 24, 2010 Storz Medical, AG Center for Devices and Radiological Health CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated Not Issued *
August 23, 2010 Sallamander Concepts CC Pty Ltd Center for Devices and Radiological Health Premarket Approval/Misbranded/Adulterated Not Issued *
August 23, 2010 Stericon Pharma Pvt. Ltd. Center for Drug Evaluation and Research CGMP for Finished Pharmaceuticals/Adulterated Not Issued *
August 16, 2010 R&P Seafood Corp. Los Angeles District Office Seafood HACCP/CGMP for Foods/Adulterated Not Issued *
August 09, 2010 Village Green Foods, Inc. Los Angeles District Office Seafood HACCP/CGMP for Foods/Adulterated Not Issued *
August 09, 2010 Diasol Inc Los Angeles District Office CGMP/QSR/Medical Devices/Adulterated Not Issued *
August 05, 2010 BioVeda Florida District Office Premarket Approval/Misbranded/Adulterated Not Issued *
August 03, 2010 Baxter Healthcare Corp Dba Biolife Plasma Center for Biologics Evaluation and Research Misleading Efficacy Claim Not Issued *
June 21, 2010 Alphatec Spine, Inc. Los Angeles District Office CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated/Misbranded Not Issued *
May 12, 2010 Laboratorios L.O., Oftalmi, C.A. Center for Drug Evaluation and Research CGMP for Finished Pharmaceuticals/Adulterated Not Issued *
-
Contact Us
*
Dockets Management
* 301-827-6860
* Fax: 301-827-6870
Division of Dockets Management
Food and Drug Administration
5630 Fishers Lane
Room 1061, HFA-305
Rockville, MD 20852
-
-
-
Links on this page:
1. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2010/default.htm
2. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2009/default.htm
3. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2008/default.htm
4. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2007/default.htm
5. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2006/default.htm
6. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2005/default.htm
7. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2004/default.htm
8. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2003/default.htm
9. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2002/default.htm
10. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2001/default.htm
11. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2000/default.htm
12. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1999/default.htm
13. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1998/default.htm
14. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1997/default.htm
15. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1996/default.htm
16. http://www.fda.govhttps://service.govdelivery.com/service/subscribe.html?code=USFDA_63
17. http://www.accessdata.fda.gov/scripts/warningletters/wlAdvancedSearch.cfm
18. http://www.accessdata.fda.gov/scripts/warningletters/wlFilterByCompany.cfm
19. http://www.accessdata.fda.gov/scripts/warningletters/wlFilterByOffice.cfm
20. http://www.accessdata.fda.gov/scripts/warningletters/wlFilterBySubject.cfm
21. http://www.accessdata.fda.gov/scripts/warningletters/wlSearchResult.cfm?company=&_1_issueDt=&_2_issueDt=&office=&subject=&hasResponseLetter=Yes&hasCloseoutLetter=Both&recsPerPageDef=500&Search=Search&errMsg=
22. http://www.accessdata.fda.gov/scripts/warningletters/wlSearchResult.cfm?company=&_1_issueDt=&_2_issueDt=&office=&subject=&hasResponseLetter=Both&hasCloseoutLetter=Yes&recsPerPageDef=500&Search=Search&errMsg=
23. http://www.accessdata.fda.gov/scripts/warningletters/wlSearchExcel.cfm
24. http://www.fda.gov/RegulatoryInformation/FOI/WhotoContactAboutFOIA/default.htm
25. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224023.htm
26. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224177.htm
27. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224014.htm
28. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224465.htm
29. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223965.htm
30. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223902.htm
31. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223971.htm
32. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223938.htm
33. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223688.htm
34. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm224225.htm
35. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223696.htm
36. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223911.htm
Page Last Updated: 06/24/2010
web sites:
http://www.addictivetips.com/
addictivetips com web site
http://www.nasa.gov/multimedia/imagegallery/
nasa gov multimedia image gallery web site
useful free online services:
let simon decide
http://www.letsimondecide.com/
http://hunch.com/
http://www.measy.com/
CDC Hurricane Health & Safety Tip
...
From:
CDC
Tip of the Week: As you prepare for Hurricane, remember to take rubber boots, rubber gloves and goggles with you when you evacuate. They will protect you from
contaminated flood waters when you return after the storm.
Subscribe to:
Posts (Atom)
image of registry return receipt of letter addressed to Makati councilor J. J. Binay
